subject: UMLS:C3827102

object_name: Stage III Prostate Cancer AJCC v8


subject: UMLS:C3827102

subject_name: PSMA-targeting Fluorescent Imaging Agent MDX1201-A488

object_name: Stage III Prostate Cancer AJCC v7

tested_intervention: yes


subject: UMLS:C3827102

object_name: Carcinoma of the prostate stage III


subject: UMLS:C3827102

object_name: Stage III Prostate Cancer AJCC v6


subject: UMLS:C3827102

object_name: prostate adenocarcinoma


subject: CHEBI:127342

subject_name: Atomoxetine

object_name: alcohol sensitivity


subject: DRUGBANK:DB09106

subject_name: hetastarch

object_name: Physical trauma


subject: DRUGBANK:DB09106

object_name: Injury


subject: DRUGBANK:DB09106

object_name: Trauma


subject: CHEBI:176724

subject_name: Etiracetam

object_name: subarachnoid hemorrhage

tested_intervention: unsure


subject: UNII:73HC18Y1LW

subject_name: LEVITIRACETAM


subject: CHEBI:6437

subject_name: Levetiracetam


subject: CHEBI:8107

subject_name: Phenytoin


subject: PUBCHEM.COMPOUND:139266768

subject_name: Injectafer

object_name: Hypoxemia


subject: PUBCHEM.COMPOUND:139266768

object_name: Hypoxia, CTCAE


subject: UNII:6897GXD6OE


subject: UNII:6897GXD6OE


subject: CHEBI:35471

subject_name: psychotropic drug

object_name: toxoplasmosis


subject: CHEBI:35471

object_name: borderline personality disorder


subject: UMLS:C0033978

subject_name: Psychotropic Drugs


subject: UMLS:C0033978


subject: DRUGBANK:DB18683

object_name: Neck Carcinoma


subject: DRUGBANK:DB18683

object_name: head and neck neoplasm


subject: DRUGBANK:DB18683

object_name: head and neck cancer


subject: DRUGBANK:DB18683

object_name: oropharynx squamous cell carcinoma


subject: DRUGBANK:DB18683

object_name: oral cavity squamous cell carcinoma


subject: UMLS:C5401611

subject_name: Washed Microbiota Transplantation

object_name: Atopic rhinitis


subject: MESH:C000612975

subject_name: Tokuyama Shield Force Plus

object_name: dentin sensitivity


subject: CHEBI:79699

subject_name: Temsirolimus

object_name: liver cancer


subject: CHEBI:79699

object_name: liver neoplasm


subject: CHEBI:79699

object_name: Adult Liver Carcinoma


subject: CHEBI:9017

subject_name: Salvianolic acid A

object_name: stroke disorder


subject: CHEBI:9017

object_name: cerebrovascular disorder


subject: CHEBI:9017

object_name: Stroke (heart beat)


subject: CHEBI:9017

object_name: Stroke, CTCAE


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:41879

object_name: Stage III Intrahepatic Cholangiocarcinoma AJCC v8


subject: CHEBI:41879

object_name: Stage IV Intrahepatic Cholangiocarcinoma AJCC v8


subject: CHEBI:41879

object_name: Stage IIIA Intrahepatic Cholangiocarcinoma AJCC v8


subject: CHEBI:41879

object_name: Stage IIIB Intrahepatic Cholangiocarcinoma AJCC v8


subject: CHEBI:193615


subject: CHEBI:193615


subject: CHEBI:193615


subject: CHEBI:193615


subject: CHEBI:193615


subject: CHEBI:60761

subject_name: Floxuridine


subject: CHEBI:60761


subject: CHEBI:60761


subject: CHEBI:60761


subject: CHEBI:60761


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:191174

subject_name: Pteroyl-D-glutamic acid


subject: CHEBI:191174


subject: CHEBI:191174


subject: CHEBI:191174


subject: CHEBI:191174


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: CHEBI:41423

subject_name: Celecoxib

object_name: laryngeal papillomatosis


subject: CHEBI:41423

object_name: larynx squamous papilloma


subject: CHEBI:4911

subject_name: Etoposide

object_name: beta thalassemia


subject: CHEBI:4911

object_name: beta-thalassemia HBB/LCRB


subject: UNII:6897GXD6OE

object_name: Surgical Complication


subject: UNII:6897GXD6OE

object_name: anemia deficiency iron treatment


subject: UNII:6897GXD6OE

object_name: iron loading anemia


subject: UMLS:C2984024

subject_name: Ferric Carboxymaltose Solution


subject: UMLS:C2984024


subject: UMLS:C2984024


subject: CHEBI:28915

subject_name: Fosfomycin


subject: CHEBI:28915


subject: CHEBI:28915


subject: CHEBI:40133

subject_name: (R)-Rolipram

object_name: Huntington disease


subject: CHEBI:104872

subject_name: Rolipram


subject: PUBCHEM.COMPOUND:54676860

object_name: Pancreatic adenocarcinoma metastatic


subject: CHEBI:22651

subject_name: ascorbate


subject: CHEBI:167715

subject_name: L-ascorbic acid 2-sulfate


subject: UMLS:C2745673

subject_name: huachansu

object_name: liver carcinoma


subject: CHEBI:5118

subject_name: Fluoxetine

object_name: cytokine release syndrome


subject: CHEBI:5118

object_name: Cytokine storm


subject: UMLS:C2984198

subject_name: Anti-VEGF Anticalin PRS-050-PEG40

object_name: Childhood Solid Neoplasm


subject: UMLS:C2984198

object_name: Adult Solid Neoplasm


subject: UMLS:C2984198

object_name: Solid Neoplasm


subject: UNII:D0VK52NV5M

subject_name: Asimadoline

object_name: Diarrhea predominant irritable bowel syndrome


subject: CHEBI:41500

subject_name: Phenylbutyrates

object_name: brain cancer


subject: CHEBI:41500

object_name: Childhood Neuroblastoma


subject: CHEBI:41500

object_name: neuroblastoma


subject: CHEBI:125354

subject_name: Plerixafor

object_name: Glioblastoma with Primitive Neuronal Component


subject: CHEBI:125354

object_name: Oligodendroglial Component Present


subject: CHEBI:125354

object_name: malignant glioma


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED


subject: UMLS:C0919079


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: UMLS:C5848866

subject_name: Immunotherapy [APC]

object_name: Neoplasm of the genitourinary tract


subject: CHEBI:36796

subject_name: duloxetine

object_name: myalgic encephalomeyelitis/chronic fatigue syndrome


subject: UMLS:C3827082

object_name: invasive ductal breast carcinoma


subject: CHEBI:49140

object_name: Parkinson disease


subject: CHEBI:31617

subject_name: fludeoxyglucose (18F)


subject: CHEBI:53498

subject_name: triacetylcellulose

object_name: graft versus host disease


subject: CHEBI:53498

object_name: mucositis


subject: UMLS:C2962221

subject_name: TAC


subject: UMLS:C2962221


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:167450

subject_name: Monomethyl fumarate


subject: CHEBI:44185

subject_name: Methotrexate


subject: UniProtKB:P47802

subject_name: MTX1_MOUSE Metaxin-1 (sprot)


subject: PR:000010755


subject: UMLS:C5557248

subject_name: Adenosine A2A Receptor Antagonist TT-10

object_name: endometrial cancer


subject: UMLS:C5557248

object_name: uterine corpus cancer


subject: UMLS:C5557248

object_name: endometrial carcinoma


subject: UMLS:C5557248

object_name: head and neck squamous cell carcinoma


subject: UMLS:C5557248

object_name: non-small cell lung carcinoma


subject: UMLS:C5557248

object_name: renal cell adenocarcinoma


subject: UMLS:C5557248

object_name: kidney cancer


subject: UMLS:C5557248

object_name: renal cell carcinoma


subject: UMLS:C5557248

object_name: childhood kidney cell carcinoma


subject: UMLS:C5557248

object_name: ovarian cancer


subject: UMLS:C5557248

object_name: ovarian neoplasm


subject: UMLS:C5557248

object_name: ovarian carcinoma


subject: UMLS:C5557250

subject_name: Adenosine A2B Receptor Antagonist TT-4


subject: UMLS:C5557250


subject: UMLS:C5557250


subject: UMLS:C5557250


subject: UMLS:C5557250


subject: UMLS:C5557250


subject: UMLS:C5557250


subject: UMLS:C5557250


subject: UMLS:C5557250


subject: UMLS:C5557250


subject: UMLS:C5557250


subject: UMLS:C5557250


subject: CHEBI:87631

subject_name: statin

object_name: paroxysmal atrial fibrillation


subject: CHEBI:87631

object_name: Paroxysmal Atrial Fibrillation by ECG Finding


subject: CHEBI:9150

subject_name: Simvastatin


subject: CHEBI:9150


subject: UMLS:C4740903

subject_name: emapalumab-lzsg

object_name: Rare Diseases


subject: UMLS:C3253111

object_name: colorectal cancer


subject: UMLS:C3253111

object_name: colorectal carcinoma


subject: UMLS:C3253111

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C4727698

subject_name: Miptenalimab

object_name: head and neck neoplasm


subject: PUBCHEM.COMPOUND:3080587

subject_name: Megestrol

object_name: AIDS


subject: PUBCHEM.COMPOUND:3080587

object_name: HIV wasting syndrome


subject: UNII:CWG62Q1VTB

subject_name: Sitravatinib

object_name: Hepatic impairment


subject: UMLS:C5854544

subject_name: SIK3 Inhibitor OMX-0407

object_name: Childhood Solid Neoplasm


subject: UMLS:C5854544

object_name: Adult Solid Neoplasm


subject: UMLS:C5854544

object_name: Solid Neoplasm


subject: DRUGBANK:DB16612

subject_name: Bee pollen

object_name: Rhinoconjunctivitis


subject: PUBCHEM.COMPOUND:66555030

subject_name: Oliceridine

object_name: Opioid analgesic adverse reaction


subject: UMLS:C3491843

object_name: Leber hereditary optic neuropathy


subject: PUBCHEM.COMPOUND:54675783

subject_name: minocycline

object_name: irradiation; adverse effect


subject: UMLS:C1174836

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: DRUGBANK:DB16536

subject_name: Birch bark extract

object_name: epidermolysis bullosa


subject: UMLS:C5669860


subject: UMLS:C2607549

object_name: Deep vein thrombosis of lower limb


subject: UNII:YI437801BE

subject_name: Mogamulizumab

object_name: recurrent cutaneous T-cell lymphoma


subject: UNII:YI437801BE

object_name: Cutaneous T-cell lymphoma refractory


subject: UMLS:C1831941


subject: UMLS:C1831941


subject: CHEBI:233197

subject_name: devimistat

object_name: granulocytic sarcoma


subject: CHEBI:233197

object_name: myeloid sarcoma


subject: CHEBI:233197

object_name: Refractory acute myeloid leukemia


subject: CHEBI:233197

object_name: Relapsing acute myeloid leukemia


subject: UNII:E76113IR49

subject_name: Devimistat


subject: UNII:E76113IR49


subject: UNII:E76113IR49


subject: UNII:E76113IR49


subject: UMLS:C2703200

subject_name: CPI 613


subject: UMLS:C2703200


subject: UMLS:C2703200


subject: UMLS:C2703200


subject: CHEBI:6801

subject_name: Metformin


subject: CHEBI:6801


subject: CHEBI:6801


subject: CHEBI:6801


subject: CHEBI:136048

subject_name: Vonoprazan

object_name: portal hypertension


subject: CHEBI:136048

object_name: Portal Hypertension, CTCAE


subject: CHEBI:136048

object_name: Bleeding varices


subject: CHEBI:136048

object_name: Bleeding ulcer


subject: CHEBI:3745

subject_name: clindamycin

object_name: non-small cell lung carcinoma


subject: CHEBI:205919

subject_name: Clobetasol


subject: CHEBI:60787

subject_name: TIMOLOL


subject: CHEBI:39465

subject_name: timolol


subject: CHEBI:29708

subject_name: Zinc gluconate


subject: CHEBI:33198

subject_name: Gluconic Acid


subject: PUBCHEM.COMPOUND:23664049

subject_name: SODIUM GLUCONATE


subject: PUBCHEM.COMPOUND:633097

subject_name: Kenalog

object_name: Macular edema of left eye due to diabetes mellitus


subject: CHEBI:9667

subject_name: Triamcinolone


subject: GTOPDB:7730

subject_name: bococizumab

object_name: inherited lipid metabolism disorder


subject: GTOPDB:7730

object_name: Dyslipidemia


subject: CHEMBL.COMPOUND:CHEMBL3137349

subject_name: BOCOCIZUMAB


subject: CHEMBL.COMPOUND:CHEMBL3137349


subject: UMLS:C4043705


subject: UMLS:C4043705


subject: CHEBI:10034

subject_name: warfarin sodium

object_name: anticoagulants; increased


subject: CHEBI:10034

object_name: heart valve disorder


subject: CHEBI:10033

subject_name: Warfarin


subject: CHEBI:94686

subject_name: Orlistat

object_name: Polybrominated biphenyl poisoning


subject: UMLS:C5666926

subject_name: Anti-CD47/Anti-PD-L1 Bispecific Antibody 6MW3211

object_name: adult lymphoma


subject: UMLS:C5666926

object_name: lymphoma


subject: UMLS:C5666926

object_name: pediatric lymphoma


subject: UMLS:C1135618

subject_name: Dermatophagoides farinae antigen

object_name: Dust mite allergy


subject: DRUGBANK:DB10400

subject_name: Dermatophagoides farinae


subject: CHEBI:91397

subject_name: Ibrutinib

object_name: CCND3 Positive


subject: CHEBI:91397

object_name: CCND2 Positive


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UNII:4F4X42SYQ6


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: CHEBI:27589

subject_name: procyanidin B4

object_name: Blood Pressure Finding


subject: CHEBI:27589

object_name: Systemic arterial pressure


subject: CHEBI:166895

subject_name: procyanidin


subject: CHEBI:166895


subject: UMLS:C4508793

object_name: cataract


subject: UMLS:C4508793

object_name: Cataract, CTCAE 3.0


subject: UMLS:C4508793

object_name: Cataract, CTCAE 5.0


subject: UMLS:C4508793

object_name: cataract on exam (physical finding)


subject: CHEBI:60648

subject_name: DOXYCYCLINE

object_name: Mycoplasma Infections


subject: CHEBI:60648

object_name: persian gulf syndrome


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: PUBCHEM.COMPOUND:54671203


subject: CHEBI:57986

object_name: hypertension


subject: UMLS:C3714502

subject_name: Riboflavin Drug Class


subject: CHEBI:17621

subject_name: FMN


subject: CHEBI:8988

object_name: Advanced Esophageal Squamous Cell Carcinoma


subject: CHEBI:80630

subject_name: Irinotecan


subject: UMLS:C5418777

subject_name: Simmitinib


subject: CHEBI:6754

subject_name: Meperidine

object_name: Gastrointestinal dysfunction


subject: CHEBI:6754

object_name: Cognitive changes


subject: CHEBI:6931

subject_name: Midazolam


subject: CHEBI:6931


subject: CHEBI:44915

subject_name: Propofol


subject: CHEBI:8802

subject_name: Remifentanil


subject: CHEBI:8802


subject: CHEBI:74699

subject_name: Met-Asp

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:74699

object_name: obesity


subject: CHEBI:74699

object_name: Obesity, CTCAE


subject: CHEBI:33395

subject_name: Mendelevium


subject: CHEBI:33395


subject: CHEBI:33395


subject: CHEBI:6823

subject_name: Methdilazine


subject: CHEBI:6823


subject: CHEBI:6823


subject: DRUGBANK:DB16541

subject_name: Lactobacillus casei

object_name: Constipation


subject: DRUGBANK:DB16541

object_name: Constipation, CTCAE


subject: UMLS:C1446492

subject_name: Ficus carica antigen

object_name: Functional constipation


subject: UMLS:C5854603

subject_name: DGKalpha Inhibitor BAY 2862789

object_name: non-small cell lung carcinoma


subject: UMLS:C0487940

subject_name: Lb substance

object_name: opioid use


subject: UMLS:C0487940

object_name: Acute Pain


subject: UNII:6T4O391P5Y

subject_name: Vactosertib

object_name: pediatric osteosarcoma


subject: UNII:6T4O391P5Y

object_name: Osteosarcoma


subject: CHEBI:15927

subject_name: Nicotinamide riboside

object_name: inborn mitochondrial metabolism disorder


subject: CHEBI:15927

object_name: mitochondrial disease


subject: CHEBI:15927

object_name: Mitochondrial DNA deletion


subject: CHEBI:15927

object_name: progressive external ophthalmoplegia


subject: CHEBI:15927

object_name: Progressive external ophthalmoplegia


subject: CHEBI:15927

object_name: Progressive ophthalmoplegia


subject: CHEBI:15927

object_name: MELAS syndrome


subject: PUBCHEM.COMPOUND:56841751

subject_name: Epidermal Growth Factor

object_name: Postinflammatory hyperpigmentation


subject: PUBCHEM.COMPOUND:56841751

object_name: hyperpigmentation of the skin


subject: PUBCHEM.COMPOUND:56841751

object_name: Hyperpigmentation, CTCAE


subject: PR:000006928

subject_name: pre-pro-epidermal growth factor


subject: PR:000006928


subject: PR:000006928


subject: PR:000060269

subject_name: epidermal growth factor


subject: PR:000060269


subject: PR:000060269


subject: CHEBI:140739

subject_name: Glu-Gly-Phe


subject: CHEBI:140739


subject: CHEBI:140739


subject: GTOPDB:4916

subject_name: EGF


subject: GTOPDB:4916


subject: GTOPDB:4916


subject: UMLS:C4049031

subject_name: Bupivacaine Hydrochloride 2.5 MG/ML includes Injectable Solution and Injection

object_name: Post-Operative Pain


subject: PUBCHEM.COMPOUND:154699459

subject_name: taletrectinib

object_name: Carcinoma breast stage IV


subject: PUBCHEM.COMPOUND:154699459

object_name: Childhood Breast Carcinoma


subject: PUBCHEM.COMPOUND:154699459

object_name: breast carcinoma


subject: PUBCHEM.COMPOUND:154699459

object_name: breast cancer


subject: CHEBI:93775

subject_name: Amethopterin

object_name: pulmonary sarcoidosis


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:127342

subject_name: Atomoxetine

object_name: Generalized social phobia


subject: CHEBI:63611

subject_name: Moxifloxacin

object_name: diabetic hyperglycaemia


subject: CHEBI:63611

object_name: torsades de pointes


subject: CHEBI:28918

subject_name: Epinephrine


subject: PR:000016279

subject_name: tissue factor pathway inhibitor


subject: CHEBI:15365

subject_name: Aspirin

object_name: intermittent vascular claudication


subject: CHEBI:17061

subject_name: D-Glutamine

object_name: perinatal necrotizing enterocolitis


subject: CHEBI:17061

object_name: neuroendocrine carcinoma


subject: CHEBI:17061

object_name: necrotizing enterocolitis


subject: CHEBI:28300

subject_name: glutamine


subject: CHEBI:28300


subject: CHEBI:28300


subject: CHEBI:18050

subject_name: L-Glutamine


subject: CHEBI:18050


subject: CHEBI:18050


subject: CHEBI:32682

subject_name: L-argininium


subject: CHEBI:32682


subject: CHEBI:32682


subject: CHEBI:29952

subject_name: L-arginine residue


subject: CHEBI:29952


subject: CHEBI:29952


subject: CHEBI:16467

subject_name: Arginine


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: Advanced Extrapulmonary Neuroendocrine Carcinoma


subject: UNII:52CMI0WC3Y

object_name: Metastatic Extrapulmonary Neuroendocrine Carcinoma


subject: UNII:52CMI0WC3Y

object_name: Recurrent Extrapulmonary Neuroendocrine Carcinoma


subject: UNII:52CMI0WC3Y

object_name: Unresectable Extrapulmonary Neuroendocrine Carcinoma


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: CHEBI:29007

subject_name: Ceftriaxone

object_name: Community-Acquired Pneumonia


subject: CHEBI:7809

subject_name: Oxacillin


subject: UMLS:C0041044

object_name: granulomatosis with polyangiitis


subject: UMLS:C1175067

object_name: castration-resistant prostate carcinoma


subject: UMLS:C1175067

object_name: prostate cancer


subject: UMLS:C1175067

object_name: prostate neoplasm


subject: CHEBI:31596

subject_name: Febuxostat

object_name: coronary microvascular disorder


subject: CHEBI:31596

object_name: end stage renal failure


subject: CHEBI:31596

object_name: Chronic uremia


subject: PUBCHEM.COMPOUND:78357831

subject_name: micafungin

object_name: Candida sepsis


subject: UMLS:C0879264


subject: UNII:43K1W2T1M6

subject_name: Interferon alfa-2b

object_name: adult lymphoma


subject: UNII:43K1W2T1M6

object_name: lymphoma


subject: UNII:43K1W2T1M6

object_name: pediatric lymphoma


subject: UMLS:C1610033

subject_name: Interferon Alpha, Human


subject: UMLS:C1610033


subject: UMLS:C1610033


subject: PR:000024938

subject_name: interferon alpha


subject: PR:000024938


subject: PR:000024938


subject: UMLS:C2825023

subject_name: Interferon alpha [EPC]


subject: UMLS:C2825023


subject: UMLS:C2825023


subject: HMDB:HMDB0013470

subject_name: LPS with O-antigen


subject: HMDB:HMDB0013470


subject: HMDB:HMDB0013470


subject: CHEBI:52603


subject: CHEBI:52603


subject: CHEBI:52603


subject: GTOPDB:5019

subject_name: LPS


subject: GTOPDB:5019


subject: GTOPDB:5019


subject: CHEBI:16412

subject_name: Lysophosphotidylserine


subject: CHEBI:16412


subject: CHEBI:16412


subject: CHEBI:89981

subject_name: Endotoxins


subject: CHEBI:89981


subject: CHEBI:89981


subject: CHEMBL.COMPOUND:CHEMBL4630622


subject: CHEMBL.COMPOUND:CHEMBL4630622


subject: CHEMBL.COMPOUND:CHEMBL4630622


subject: PR:000001155

subject_name: Toll-like receptor 4


subject: PR:000001155


subject: PR:000001155


subject: CHEBI:28072

object_name: Chronic obstructive pulmonary disease of horses


subject: CHEBI:28072

object_name: COPD, severe early onset


subject: CHEBI:28072

object_name: chronic obstructive pulmonary disease


subject: CHEBI:70744

subject_name: Gly-Pro


subject: CHEBI:70744


subject: CHEBI:70744


subject: UniProtKB:P08668

subject_name: GP_HANTV Envelopment polyprotein (sprot)


subject: UniProtKB:P08668


subject: UniProtKB:P08668


subject: UniProtKB:P27312

subject_name: GP_PUUMS Envelopment polyprotein (sprot)


subject: UniProtKB:P27312


subject: UniProtKB:P27312


subject: CHEBI:73915

subject_name: Gly-Phe-Phe


subject: CHEBI:73915


subject: UMLS:C5667092

subject_name: HER2 Inhibitor SPH5030

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:73462

subject_name: Cys-Ser

object_name: Aortic stiffness


subject: CHEBI:73462

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:73462

object_name: Insulin resistance syndrome


subject: CHEBI:73462

object_name: metabolic syndrome X


subject: CHEBI:73462

object_name: Pediatric Obesity


subject: CHEBI:73462

object_name: inherited lipid metabolism disorder


subject: CHEBI:73462

object_name: Dyslipidemia


subject: CHEBI:30514

subject_name: caesium atom


subject: CHEBI:30514


subject: CHEBI:30514


subject: CHEBI:30514


subject: CHEBI:30514


subject: CHEBI:30514


subject: CHEBI:30514


subject: UMLS:C0002932

subject_name: Anesthetics

object_name: neurotoxicity


subject: DRUGBANK:DB14101

subject_name: Soy isoflavones

object_name: Wheezing


subject: DRUGBANK:DB14101

object_name: Wheezing, CTCAE


subject: DRUGBANK:DB14101

object_name: childhood onset asthma


subject: CHEBI:77323

subject_name: Ethoxyquin

object_name: amphetamine abuse


subject: CHEBI:48723

subject_name: Lobeline


subject: UNII:2Y3T5IF01Z

subject_name: Retifanlimab

object_name: carcinoid syndrome


subject: UNII:2Y3T5IF01Z

object_name: Advanced Neuroendocrine Neoplasm


subject: UMLS:C4688466

subject_name: INCMGA 0012


subject: UMLS:C4688466


subject: UNII:8G388563M7

subject_name: Telotristat ethyl


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: Atheroma


subject: UMLS:C5203186

subject_name: Atezolizumab Liquid Injection

object_name: Advanced Neuroendocrine Carcinoma


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab


subject: UMLS:C5203352

subject_name: Carboplatin Liquid Injection


subject: UMLS:C0499106

subject_name: Injection, carboplatin, 50 mg


subject: UMLS:C5400115

subject_name: Cisplatin Liquid Injection


subject: UMLS:C0499127

subject_name: Injection, etoposide, 10 mg administered


subject: UMLS:C5203273

subject_name: Etoposide Liquid Injection


subject: CHEBI:4911

subject_name: Etoposide


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: UMLS:C5446537

subject_name: Inhaled Voriconazole

object_name: allergic bronchopulmonary aspergillosis


subject: PUBCHEM.COMPOUND:2767

object_name: metastatic squamous cell carcinoma


subject: UMLS:C5417792

subject_name: MC1R Agonist MT-7117

object_name: kidney failure


subject: UMLS:C5417792

object_name: Normal renal function


subject: UMLS:C5555832

subject_name: Anti-PD-L1/Anti-4-1BB Bispecific Antibody ABL503

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C3640989

object_name: primary central nervous system lymphoma


subject: MESH:C000712209

object_name: multiple sclerosis


subject: MESH:C000654530


subject: CHEBI:41423

subject_name: Celecoxib


subject: CHEBI:6128

subject_name: Ketoprofen


subject: UMLS:C0062085

subject_name: Haemophilus influenzae-type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine

object_name: diphtheria


subject: UMLS:C0062085

object_name: poliomyelitis


subject: UMLS:C0062085

object_name: hepatitis B


subject: UMLS:C0062085

object_name: pertussis


subject: UMLS:C0062085

object_name: tetanus


subject: UMLS:C1709400

object_name: head and neck squamous cell carcinoma


subject: CHEBI:64342

subject_name: 3-hydroxypicolinic acid

object_name: anxiety


subject: CHEBI:64342

object_name: anxiety disorder


subject: CHEBI:64342

object_name: Anxiety symptoms


subject: CHEBI:64342

object_name: Anxiety, CTCAE 3.0


subject: CHEBI:64342

object_name: Anxiety, CTCAE 5.0


subject: MESH:D016824

subject_name: Antigens, Human Platelet


subject: MESH:D016824


subject: MESH:D016824


subject: MESH:D016824


subject: MESH:D016824


subject: CHEBI:53393

subject_name: heteropolyacid macromolecule


subject: CHEBI:53393


subject: CHEBI:53393


subject: CHEBI:53393


subject: CHEBI:53393


subject: CHEBI:61431

subject_name: heteropolyacid polymer


subject: CHEBI:61431


subject: CHEBI:61431


subject: CHEBI:61431


subject: CHEBI:61431


subject: CHEBI:29031

subject_name: phosphinic acid


subject: CHEBI:29031


subject: CHEBI:29031


subject: CHEBI:29031


subject: CHEBI:29031


subject: PR:000008741

subject_name: heparanase


subject: PR:000008741


subject: PR:000008741


subject: PR:000008741


subject: PR:000008741


subject: UMLS:C4287726

subject_name: Topoisomerase I/II Inhibitor NEV-801

object_name: Advanced cancer


subject: UMLS:C4287726

object_name: Solid Neoplasm


subject: UNII:UG5KU6AQ0Z

object_name: pemphigus vulgaris


subject: UMLS:C4541803


subject: CHEBI:109549

subject_name: Ramelteon

object_name: panic disorder


subject: CHEBI:109549

object_name: panic disorder 1


subject: UMLS:C5785437

subject_name: TLR7 Agonist CAN1012

object_name: Advanced Malignant Solid Neoplasm


subject: PUBCHEM.COMPOUND:138713709

subject_name: deucravacitinib

object_name: pyoderma gangrenosum


subject: CHEBI:63577

subject_name: Lamivudine

object_name: Alzheimer Disease, Early Onset


subject: UNII:3H8GSZ4SQL

subject_name: Avatrombopag

object_name: adult lymphoma


subject: UNII:3H8GSZ4SQL

object_name: lymphoma


subject: UNII:3H8GSZ4SQL

object_name: pediatric lymphoma


subject: UNII:3H8GSZ4SQL

object_name: Cytarabine causing adverse effects in therapeutic use


subject: CHEBI:74705

subject_name: Met-Leu

object_name: Waldenstrom macroglobulinemia


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: CHEBI:36005

subject_name: docosahexaenoic acid

object_name: Infant Malnutrition


subject: CHEBI:36005

object_name: Infant Nutrition Disorders


subject: CHEBI:36005

object_name: Light-for-dates with signs of fetal malnutrition


subject: CHEBI:16016

subject_name: Glycerone


subject: CHEBI:16016


subject: CHEBI:16016


subject: CHEBI:28689

subject_name: Prasterone


subject: CHEBI:28689


subject: CHEBI:28689


subject: CHEBI:28125

subject_name: Doconexent


subject: CHEBI:28125


subject: CHEBI:28125


subject: UMLS:C0873173

subject_name: red yeast rice extract

object_name: Hyperlipidemia, group A


subject: UMLS:C0873173

object_name: Dyslipidemia


subject: UNII:BTY153760O

subject_name: Ixekizumab

object_name: lichen planus


subject: UNII:BTY153760O

object_name: lichen planopilaris


subject: UNII:BTY153760O

object_name: Cicatricial alopecia due to lichen planus


subject: UMLS:C4045962

object_name: hepatitis C


subject: PUBCHEM.COMPOUND:23594367

subject_name: Boceprevir

object_name: Cirrhosis


subject: PUBCHEM.COMPOUND:23594367

object_name: liver cirrhosis


subject: CHEBI:68595

subject_name: Telaprevir


subject: CHEBI:68595


subject: CHEBI:50858

subject_name: corticosteroid

object_name: Post-Operative Pain


subject: MESH:D000305

subject_name: Adrenal Cortex Hormones


subject: UMLS:C3536709

subject_name: Corticosteroid [EPC]


subject: CHEBI:230430

subject_name: Ulinastatin

object_name: Inflammatory Response


subject: UNII:OR3S9IF86U

subject_name: urinastatin


subject: CHEMBL.COMPOUND:CHEMBL2108163

subject_name: ULINASTATIN


subject: UMLS:C0077906


subject: UNII:MRL3739G66

subject_name: Dotatate

object_name: Recurrent Meningioma


subject: PUBCHEM.COMPOUND:66586232

object_name: Oral hygiene status


subject: CHEBI:3614

subject_name: Chlorhexidine


subject: CHEBI:45716

subject_name: Vorinostat

object_name: bone marrow disorder


subject: CHEBI:45716

object_name: blood disease


subject: GTOPDB:13720

object_name: anthrax disease


subject: CHEMBL.COMPOUND:CHEMBL2109303


subject: UMLS:C4079466


subject: CHEBI:76842

object_name: Clostridium difficile diarrhea


subject: CHEBI:28001

subject_name: Vancomycin


subject: CHEBI:93862

object_name: rheumatoid arthritis


subject: CHEBI:64213

subject_name: Cantharidin


subject: HMDB:HMDB0013470

subject_name: LPS with O-antigen


subject: CHEBI:16412

subject_name: Lysophosphotidylserine


subject: PUBCHEM.COMPOUND:155977629


subject: CHEBI:89981

subject_name: Endotoxins


subject: CHEBI:6413

subject_name: Letrozole

object_name: abortion in first trimester


subject: PUBCHEM.COMPOUND:53395091

object_name: vitamin D deficiency


subject: CHEBI:29950

subject_name: L-cysteine residue


subject: CHEBI:16375

subject_name: D-Cysteine


subject: CHEBI:17561

subject_name: Cysteine


subject: CHEBI:133023

subject_name: Lifitegrast

object_name: Contact lens complication


subject: CHEBI:133023

object_name: Inflammatory abnormality of the eye


subject: CHEBI:133023

object_name: Ocular discomfort


subject: UNII:9013DUQ28K

subject_name: Anakinra

object_name: inflammatory disease


subject: UNII:9013DUQ28K

object_name: Autoimmunity


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UMLS:C0295415

subject_name: rituximab


subject: UNII:FU77B4U5Z0

subject_name: Ustekinumab


subject: UNII:FU77B4U5Z0


subject: CHEBI:37845

subject_name: growth hormone

object_name: Prader-Willi syndrome


subject: PUBCHEM.COMPOUND:170907453

subject_name: Growth hormone


subject: UMLS:C0037663

subject_name: Growth Hormone


subject: PR:000007968

subject_name: somatotropin


subject: CHEBI:93517

subject_name: Olvanil

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:93517

object_name: obesity


subject: CHEBI:93517

object_name: Obesity, CTCAE


subject: CHEBI:75832

subject_name: ferrous sulfate

object_name: Fatigue, CTCAE 5.0


subject: CHEBI:75832

object_name: Fatigue


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: genetic disease


subject: CHEBI:5001

subject_name: Fenofibrate


subject: CHEBI:15940

subject_name: Niacin


subject: CHEBI:17154

subject_name: Nicotinamide


subject: UMLS:C4283878

subject_name: Neutrophil Activation Probe Imaging Agent

object_name: non-small cell lung carcinoma


subject: PR:000010986

subject_name: napsin-A


subject: PR:000006011

subject_name: beta-catenin-like protein 1


subject: UMLS:C3273933

subject_name: Hafnium oxide-containing nanoparticles nbtxr3

object_name: Microsatellite instability-high solid malignant tumor


subject: UMLS:C3273933

object_name: head and neck squamous cell carcinoma


subject: UMLS:C3273933

object_name: Metastatic Triple-Negative Breast Carcinoma


subject: UMLS:C3273933

object_name: Metastatic Renal Cell Carcinoma


subject: UMLS:C3273933

object_name: Metastatic Renal Cell Cancer


subject: UMLS:C3273933

object_name: Metastatic non-small cell lung cancer


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: History of liver recipient


subject: PUBCHEM.COMPOUND:70789204

object_name: Liver transplant recipient


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: CHEBI:61057


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:61049


subject: CHEBI:8382

subject_name: Prednisone

object_name: disseminated eosinophilic collagen disease


subject: CHEBI:8382

object_name: Eosinophilia


subject: CHEBI:8382

object_name: idiopathic hypereosinophilic syndrome


subject: CHEBI:8382

object_name: Eosinophilic disorder


subject: CHEBI:8382

object_name: Eosinophilia, CTCAE


subject: CHEBI:8382

object_name: leukocyte disorder


subject: CHEBI:8382

object_name: hematologic disorder


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: biliary tract cancer


subject: PUBCHEM.COMPOUND:131769963

object_name: cholangiocarcinoma


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:50924


subject: CHEBI:32016

subject_name: Pirfenidone

object_name: long COVID-19


subject: UNII:4RA0KN46E0

subject_name: Upadacitinib


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: Acute ulcerative colitis


subject: CHEBI:174615

object_name: hyper-IgM syndrome type 1


subject: CHEBI:174615

object_name: X-linked lymphoproliferative syndrome


subject: CHEBI:174615

object_name: MHC class II deficiency


subject: CHEBI:174615

object_name: reticular dysgenesis


subject: CHEBI:174615

object_name: Chediak-Higashi syndrome


subject: CHEBI:174615

object_name: Griscelli syndrome


subject: CHEBI:174615

object_name: hyper-IgM syndrome


subject: CHEBI:174615

object_name: Omenn syndrome


subject: CHEBI:28901

subject_name: Busulfan


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: hemophagocytic syndrome


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:31824

subject_name: Mesna


subject: CHEBI:31824

object_name: common variable immunodeficiency


subject: CHEBI:31824

object_name: Acquired Hypogammaglobulinemia


subject: CHEBI:31824

object_name: Langerhans cell histiocytosis


subject: CHEBI:31824


subject: CHEBI:31824


subject: CHEBI:31824

object_name: chronic granulomatous disease


subject: CHEBI:31824


subject: CHEBI:31824


subject: CHEBI:31824


subject: CHEBI:31824

object_name: Wiskott-Aldrich syndrome


subject: CHEBI:31824


subject: CHEBI:31824


subject: CHEBI:31824


subject: CHEBI:31824

object_name: severe combined immunodeficiency


subject: CHEBI:17905

subject_name: Coenzyme M


subject: CHEBI:17905


subject: CHEBI:17905


subject: CHEBI:17905


subject: CHEBI:17905


subject: CHEBI:17905


subject: CHEBI:17905


subject: CHEBI:17905


subject: CHEBI:17905


subject: CHEBI:17905


subject: CHEBI:17905


subject: CHEBI:17905


subject: CHEBI:17905


subject: CHEBI:17905


subject: CHEBI:17905


subject: CHEBI:82339

subject_name: Merphalan


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:28876

subject_name: Melphalan


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: UNII:FYS6T7F842

subject_name: Adalimumab

object_name: Focal Segmental Glomerulosclerosis, Not Otherwise Specified


subject: UNII:FYS6T7F842

object_name: lipoid nephrosis


subject: UNII:FYS6T7F842

object_name: multicentric Castleman disease


subject: UNII:FYS6T7F842

object_name: multicentric Castleman disease, susceptibility to


subject: UNII:FYS6T7F842

object_name: multiple carboxylase deficiency


subject: UNII:FYS6T7F842

object_name: macular corneal dystrophy


subject: GTOPDB:13769

subject_name: retatrutide

object_name: metabolic dysfunction-associated steatotic liver disease


subject: CHEMBL.COMPOUND:CHEMBL5095485

subject_name: RETATRUTIDE


subject: UMLS:C5206844

subject_name: FGFR4 Inhibitor ICP-105

object_name: Childhood Solid Neoplasm


subject: UMLS:C5206844

object_name: Adult Solid Neoplasm


subject: UMLS:C5206844

object_name: Solid Neoplasm


subject: CHEBI:76842

object_name: Hand Injuries and Disorders


subject: CHEBI:76842

object_name: Unspecified injury of wrist and hand


subject: CHEBI:76842

object_name: Arthritis of hand


subject: CHEBI:76842

object_name: Hand Injuries


subject: CHEBI:28001

subject_name: Vancomycin


subject: CHEBI:28001


subject: CHEBI:28001


subject: CHEBI:28001


subject: UNII:Y6BX7BL23K

subject_name: Pemigatinib

object_name: urothelial carcinoma


subject: UNII:Y6BX7BL23K

object_name: transitional cell carcinoma


subject: UNII:Y6BX7BL23K

object_name: Childhood Soft Tissue Sarcoma


subject: UNII:Y6BX7BL23K

object_name: Adult Soft Tissue Sarcoma


subject: UNII:Y6BX7BL23K

object_name: sarcoma


subject: UNII:Y6BX7BL23K

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: UNII:Y6BX7BL23K

object_name: soft tissue sarcoma


subject: UNII:Y6BX7BL23K

object_name: breast neoplasm


subject: CHEBI:68558

subject_name: Ticagrelor

object_name: vascular inflammations


subject: CHEBI:9168

subject_name: Sirolimus

object_name: skin atrophy


subject: CHEBI:27812

subject_name: Methylselenocysteine

object_name: familial acute respiratory distress syndrome, ANLN-related, dog


subject: CHEBI:27812

object_name: acute respiratory distress syndrome


subject: CHEBI:27812

object_name: COVID-19-Associated Acute Respiratory Distress Syndrome


subject: CHEBI:27812

object_name: adult acute respiratory distress syndrome


subject: UMLS:C1135137

object_name: glioblastoma


subject: UMLS:C1135137

object_name: Childhood Glioblastoma


subject: UMLS:C1135137

object_name: adult glioblastoma


subject: UNII:OX5LRQ5H6K

subject_name: FIANLIMAB

object_name: Neck Carcinoma


subject: UNII:OX5LRQ5H6K

object_name: head and neck neoplasm


subject: UNII:OX5LRQ5H6K

object_name: head and neck cancer


subject: UMLS:C4329332

subject_name: Fianlimab


subject: UMLS:C4329332


subject: UMLS:C4329332


subject: UMLS:C3892863

subject_name: filgrastim-sndz

object_name: Refractory acute myeloid leukemia


subject: UMLS:C3892863

object_name: recurrent adult acute myeloid leukemia


subject: UNII:AIS8N3O50B

subject_name: Seltorexant

object_name: Insomnia, CTCAE 3.0


subject: UNII:AIS8N3O50B

object_name: Insomnia, CTCAE 5.0


subject: UMLS:C5139948


subject: UMLS:C5139948


subject: GTOPDB:7988

subject_name: nimotuzumab

object_name: Pancreatic carcinoma non-resectable


subject: UNII:6NS400BXKH


subject: UMLS:C1570308


subject: MESH:C079198

subject_name: S 1 (combination)


subject: UMLS:C0074926

subject_name: Soy Proteins

object_name: Solar elastosis


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Acquired trigger finger


subject: PUBCHEM.COMPOUND:53477758

subject_name: Oxytocin

object_name: placental retention


subject: UMLS:C0592155

subject_name: Syntocinon


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Refractory Malignant Brain Neoplasm


subject: CHEBI:4026

object_name: Recurrent Malignant Brain Neoplasm


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:42446

subject_name: Esflurbiprofen

object_name: Peri-implant mucositis


subject: CHEBI:5130

subject_name: Flurbiprofen


subject: CHEBI:139072

object_name: cocaine abuse


subject: CHEBI:8614

subject_name: Psilocybin


subject: UMLS:C1454298

subject_name: HKI 272

object_name: HER2 positive breast carcinoma


subject: CHEBI:231679

subject_name: ipilimumab

object_name: Brain Stem Glioblastoma


subject: CHEBI:231679

object_name: glioma susceptibility 1


subject: CHEBI:94531

subject_name: belinostat

object_name: plasma cell myeloma


subject: UMLS:C1452684


subject: UNII:8202AY8I7H

subject_name: Eptinezumab

object_name: cluster headache syndrome


subject: CHEMBL.COMPOUND:CHEMBL3833369

subject_name: FISH OIL

object_name: colon carcinoma


subject: CHEMBL.COMPOUND:CHEMBL3833369

object_name: colon cancer


subject: UMLS:C3897088

subject_name: Oral Azacitidine

object_name: follicular lymphoma


subject: CHEBI:45783

subject_name: Imatinib

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: CHEBI:45783

object_name: Ovarian cancer stage IV


subject: CHEBI:45783

object_name: Ovarian cancer stage III


subject: CHEBI:8228

subject_name: Pioglitazone

object_name: polycystic kidney disease


subject: UMLS:C4307657

object_name: disseminated eosinophilic collagen disease


subject: UMLS:C4307657

object_name: Eosinophilia


subject: UMLS:C4307657

object_name: idiopathic hypereosinophilic syndrome


subject: CHEBI:71200

subject_name: Tofacitinib

object_name: spondylitis


subject: CHEBI:71200

object_name: sacroilitis


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: Chronic musculoskeletal pain


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL


subject: UMLS:C1612488

subject_name: Xibrom

object_name: Bilateral cataracts (disorder)


subject: CHEBI:240107

subject_name: Bromfenac


subject: PUBCHEM.COMPOUND:4895

subject_name: Pred Forte


subject: CHEBI:8378

subject_name: Prednisolone


subject: CHEBI:17754

subject_name: Glycerin

object_name: diabetic macular edema


subject: CHEBI:55352

subject_name: (R)-Atenolol

object_name: Surgical procedure finding


subject: CHEBI:2904

subject_name: Atenolol


subject: CHEBI:101853

subject_name: Gemifloxacin

object_name: gonorrhea


subject: PUBCHEM.COMPOUND:3467

subject_name: gentamicin


subject: UMLS:C5848866

subject_name: Immunotherapy [APC]

object_name: Complete Response in Aplastic Anemia


subject: UMLS:C5848866

object_name: Global Complete Response in Lymph Nodes


subject: UMLS:C5848866

object_name: Global Complete Response in Blood


subject: UMLS:C5848866

object_name: Global Complete Response in Skin


subject: UMLS:C5848866

object_name: Global Complete Response in Viscera


subject: UMLS:C5848866

object_name: irCR (Immune-Related Response Criteria)


subject: UMLS:C5848866

object_name: Global Complete Response


subject: UMLS:C5848866

object_name: RECIL CR


subject: UMLS:C5848866

object_name: IMWG Complete Response


subject: UMLS:C5848866

object_name: Complete Remission


subject: UMLS:C5848866

object_name: nasopharyngeal neoplasm


subject: CHEBI:191043

object_name: osteoarthritis, knee


subject: CHEBI:85995

subject_name: lenvatinib mesylate

object_name: Advanced Biliary Tract Carcinoma


subject: CHEBI:85995

object_name: Advanced Bile Duct Carcinoma


subject: CHEBI:85994

subject_name: Lenvatinib


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:19FUJ2C58T

subject_name: Ginkgo biloba

object_name: psychosexual disorder


subject: UNII:19FUJ2C58T

object_name: hypoactive sexual desire disorder


subject: UMLS:C3531686

subject_name: Ginkgo biloba whole extract


subject: UMLS:C3531686


subject: UNII:53O87HA2QU

subject_name: Defactinib

object_name: pancreatic ductal adenocarcinoma


subject: UMLS:C4287688

subject_name: Chinese Herbal Formulation LC09

object_name: hand-foot syndrome


subject: UMLS:C4287688

object_name: Sickle Cell Dactylitis


subject: CHEBI:49086

object_name: neurodegenerative disease


subject: CHEBI:16436

subject_name: Citicoline


subject: MESH:D009822

subject_name: Oils, Volatile

object_name: Coronavinae infectious disease


subject: CHEBI:83630

subject_name: essential oil


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: Propofol adverse reaction


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: CHEMBL.COMPOUND:CHEMBL4594356

object_name: Advanced Malignant Solid Neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4594356

object_name: adult lymphoma


subject: CHEMBL.COMPOUND:CHEMBL4594356

object_name: lymphoma


subject: CHEMBL.COMPOUND:CHEMBL4594356

object_name: pediatric lymphoma


subject: UMLS:C4053572


subject: UMLS:C4053572


subject: UMLS:C4053572


subject: UMLS:C4053572


subject: CHEBI:90936

subject_name: Alectinib

object_name: metastatic malignant neoplasm in the brain


subject: CHEBI:64019

subject_name: Nebivolol

object_name: peripheral vascular disease


subject: CHEBI:64019

object_name: peripheral arterial disease


subject: UMLS:C3714707

subject_name: Cinnamomum zeylanicum

object_name: type 2 diabetes mellitus


subject: UNII:BI009E452R

subject_name: Andexanet alfa

object_name: Emergency surgery


subject: UMLS:C4045506


subject: CHEBI:68554

subject_name: Deferiprone

object_name: mild neurocognitive disorder


subject: CHEBI:68554

object_name: mild cognitive impairment


subject: UMLS:C5139951

object_name: cystic fibrosis


subject: UMLS:C5139951

object_name: Fibrocystic Disease of Pancreas


subject: UMLS:C5139951

object_name: Cystic fibrosis gastrointestinal disease


subject: UMLS:C5139803


subject: UMLS:C5139803


subject: MESH:C000730434

subject_name: TRPC inhibitor BI 1358894

object_name: post-traumatic stress disorder


subject: CHEBI:230905

subject_name: Ribociclib

object_name: Adult Meningioma


subject: CHEBI:230905

object_name: benign meningioma


subject: CHEBI:230905

object_name: familial meningioma


subject: CHEBI:230905

object_name: pediatric meningioma


subject: CHEBI:230905

object_name: meningioma


subject: CHEBI:145499

subject_name: Donepezil

object_name: Anorexia


subject: PUBCHEM.COMPOUND:11654566

subject_name: Idelalisib

object_name: B cells--Tumors


subject: PUBCHEM.COMPOUND:11654566

object_name: mantle cell lymphoma


subject: CHEBI:77562

subject_name: rac-crizotinib

object_name: Adenocarcinoma of lung, stage IV


subject: CHEBI:64310

subject_name: Crizotinib


subject: UNII:UPC6BTX7PY

subject_name: INCLISIRAN SODIUM


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Cervical carcinoma stage IVB


subject: UNII:2S9ZZM9Q9V

object_name: Stage IVB Cervical Cancer AJCC v8


subject: CHEBI:30742

subject_name: macrogol

object_name: liver carcinoma


subject: CHEBI:47519

subject_name: Ketoconazole

object_name: schizophrenia


subject: PR:000009060

subject_name: insulin-like peptide INSL5

object_name: tuberculosis


subject: PR:000013980

subject_name: Rho-related GTP-binding protein RhoF


subject: PR:000023845

subject_name: DNA-directed RNA polymerase subunit beta


subject: UniProtKB:P0A8V2

subject_name: RPOB_ECOLI DNA-directed RNA polymerase subunit beta (sprot)


subject: UMLS:C3890420

subject_name: Realgar-Indigo naturalis Formulation


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: Renal cell carcinoma recurrent


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage IV Renal Cell Cancer


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage IV Renal Cell Cancer AJCC v7


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:180911


subject: CHEBI:180911


subject: CHEBI:180911

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: CHEBI:180911


subject: CHEBI:45906

subject_name: Suramin


subject: CHEBI:45906


subject: CHEBI:45906


subject: CHEBI:45906


subject: CHEBI:32599

object_name: thyroid tumor


subject: UNII:7K28NB895L

subject_name: Belzutifan

object_name: vaginal cancer


subject: UNII:7K28NB895L

object_name: vaginal carcinoma


subject: UNII:7K28NB895L

object_name: ovarian cancer


subject: UNII:7K28NB895L

object_name: ovarian neoplasm


subject: UNII:7K28NB895L

object_name: ovarian carcinoma


subject: UNII:7K28NB895L

object_name: cervical cancer


subject: UNII:7K28NB895L

object_name: cervical carcinoma


subject: UNII:7K28NB895L

object_name: vulva cancer


subject: UNII:7K28NB895L

object_name: vulva carcinoma


subject: UNII:7K28NB895L

object_name: endometrial cancer


subject: UNII:7K28NB895L

object_name: uterine corpus cancer


subject: UNII:7K28NB895L

object_name: endometrial carcinoma


subject: UNII:7K28NB895L

object_name: malignant epithelial tumor of ovary


subject: UNII:7K28NB895L

object_name: female reproductive organ cancer


subject: UNII:7K28NB895L

object_name: uterine cancer


subject: UNII:7K28NB895L

object_name: tumor of uterus


subject: CHEBI:80332

subject_name: C-peptide

object_name: diabetic polyneuropathy


subject: CHEBI:80332

object_name: type 1 diabetes mellitus 1


subject: UMLS:C0006558

subject_name: C-Peptide


subject: UMLS:C0006558


subject: PUBCHEM.COMPOUND:135449332

subject_name: Eltrombopag

object_name: acute radiation syndrome


subject: UMLS:C3256731

subject_name: seaweed extract

object_name: Insulin Sensitivity


subject: UMLS:C3256731

object_name: abdominal obesity-metabolic syndrome


subject: UMLS:C3256731

object_name: metabolic syndrome X


subject: CHEMBL.COMPOUND:CHEMBL4650387

object_name: Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEMBL.COMPOUND:CHEMBL4650387

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: CHEMBL.COMPOUND:CHEMBL4650387

object_name: acute myeloid leukemia


subject: CHEMBL.COMPOUND:CHEMBL4650387

object_name: childhood acute lymphoblastic leukemia


subject: CHEMBL.COMPOUND:CHEMBL4650387

object_name: acute lymphoblastic leukemia


subject: CHEMBL.COMPOUND:CHEMBL4650387

object_name: adult acute lymphoblastic leukemia


subject: CHEMBL.COMPOUND:CHEMBL4650387

object_name: Myelodysplasia


subject: CHEMBL.COMPOUND:CHEMBL4650387

object_name: B-cell chronic lymphocytic leukemia


subject: CHEMBL.COMPOUND:CHEMBL4650387

object_name: Hodgkin Disease


subject: UMLS:C0935953

subject_name: Mobist


subject: UMLS:C0935953


subject: UMLS:C0935953


subject: UMLS:C0935953


subject: UMLS:C0935953


subject: UMLS:C0935953


subject: UMLS:C0935953


subject: UMLS:C0935953


subject: UMLS:C0935953


subject: CHEBI:125354

subject_name: Plerixafor


subject: CHEBI:125354


subject: CHEBI:125354


subject: UMLS:C5783521

subject_name: Levcromakalim Prodrug Eye Drop QLS-101

object_name: ocular hypertension


subject: UMLS:C5783521

object_name: Ocular hypertension


subject: UMLS:C5783521

object_name: OPTN-related open angle glaucoma


subject: UMLS:C5783521

object_name: open-angle glaucoma


subject: CHEBI:2663

subject_name: Amiodarone

object_name: outcomes general quality of life


subject: CHEBI:2663

object_name: Perceived quality of life


subject: CHEBI:2663

object_name: Good quality of life


subject: CHEBI:4657

subject_name: Disopyramide

object_name: atrial fibrillation


subject: CHEBI:4657

object_name: Atrial Fibrillation by ECG Finding


subject: CHEBI:4657

object_name: Atrial Fibrillation, CTCAE


subject: CHEBI:4657


subject: CHEBI:4657


subject: CHEBI:4657


subject: CHEBI:50659

subject_name: Dronedarone


subject: CHEBI:50659


subject: CHEBI:50659


subject: CHEBI:75984

subject_name: Flecainide


subject: CHEBI:75984


subject: CHEBI:75984


subject: CHEBI:63619

subject_name: Propafenone


subject: CHEBI:63619


subject: CHEBI:63619


subject: CHEBI:63622

subject_name: Sotalol


subject: CHEBI:63622


subject: CHEBI:63622


subject: CHEBI:85993

subject_name: Palbociclib

object_name: thymus cancer


subject: UMLS:C5963121

subject_name: Wee1/Myt1 Inhibitor SGR-3515

object_name: Advanced Malignant Solid Neoplasm


subject: UNII:MA10QYF1Z0

subject_name: Ferric maltol

object_name: anemia


subject: UNII:MA10QYF1Z0

object_name: Anemia, CTCAE


subject: UNII:9J765S329G

subject_name: L-Thyroxine sodium salt pentahydrate

object_name: reported prior thyroid disease (history)


subject: UNII:9J765S329G

object_name: chronic kidney disease


subject: CHEBI:6447

subject_name: levothyroxine sodium hydrate


subject: CHEBI:6447


subject: CHEBI:18332

subject_name: Levothyroxine


subject: UMLS:C0079691

subject_name: Levothroid


subject: UMLS:C0079691


subject: CHEBI:47519

subject_name: Ketoconazole

object_name: gastroparesis


subject: CHEBI:47519

object_name: Gastroparesis, CTCAE


subject: CHEBI:28918

subject_name: Epinephrine

object_name: Acute bronchiolitis caused by respiratory syncytial virus


subject: CHEBI:194548

subject_name: Racepinephrine


subject: MESH:D012462

subject_name: Saline Solution, Hypertonic


subject: CHEBI:10429

subject_name: Lapachone

object_name: squamous cell carcinoma


subject: CHEBI:10429

object_name: head and neck neoplasm


subject: UMLS:C1328233

subject_name: ARQ 501


subject: UMLS:C1328233


subject: CHEBI:63617

subject_name: Pergolide

object_name: Tourette syndrome


subject: CHEBI:134716

subject_name: Brexpiprazole

object_name: Acute mania


subject: MESH:C402943

subject_name: bu-zhong-yi-qi-tang

object_name: Atopic rhinitis


subject: MESH:C402943

object_name: Allergic Rhinitis, CTCAE


subject: UMLS:C5700342

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C5700342

object_name: clear cell renal carcinoma


subject: UMLS:C5700342

object_name: renal cell adenocarcinoma


subject: UMLS:C5700342

object_name: renal cell carcinoma


subject: CHEBI:91450

subject_name: Sapanisertib


subject: CHEBI:91450


subject: UNII:R8DG7T2D3A

subject_name: FERUMOXYTOL

object_name: temporal lobe epilepsy


subject: UNII:CLH5FT6412

subject_name: Ferumoxytol


subject: CHEBI:46726

subject_name: magnetite


subject: CHEBI:30314

subject_name: Lipoic acid

object_name: Childhood Kidney Disorder


subject: CHEBI:43796

subject_name: (S)-lipoic acid

object_name: Complication of hemodialysis


subject: CHEBI:43796


subject: CHEBI:16494

subject_name: thioctic acid


subject: CHEBI:8869

subject_name: Risedronic acid

object_name: Crohn disease


subject: CHEBI:6062

subject_name: Isosorbide mononitrate

object_name: portal hypertension


subject: CHEBI:6062

object_name: Portal Hypertension, CTCAE


subject: CHEBI:17553

object_name: high-risk pregnancy


subject: CHEBI:25879

subject_name: Pentaerythritol tetranitrate


subject: UMLS:C0030956

subject_name: Peptides

object_name: dental caries


subject: UMLS:C0030956

object_name: Dental Caries, CTCAE


subject: PR:000018264

subject_name: proteolytic cleavage product


subject: PR:000018264


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: Locally Advanced Head and Neck Squamous Cell Carcinoma


subject: UMLS:C3641122


subject: UNII:QEN1X95CIX

subject_name: Tremelimumab


subject: UMLS:C1948073


subject: UNII:363Z97G83I

object_name: Hyperuricemia


subject: UNII:363Z97G83I

object_name: Hyperuricemia, CTCAE


subject: UMLS:C4305638


subject: UMLS:C4305638


subject: UNII:J9F5ZPH7NB

subject_name: Grapiprant

object_name: inflammatory breast carcinoma


subject: UNII:J9F5ZPH7NB

object_name: Inflammatory carcinoma of breast stage IV


subject: UNII:J9F5ZPH7NB

object_name: Inflammatory carcinoma of breast recurrent


subject: UNII:7D96IR0PPM

subject_name: Pegaspargase

object_name: Drug toxicity


subject: CHEBI:172923

subject_name: FLUORESCEIN

object_name: cerebrovascular disorder


subject: CHEBI:157844

subject_name: Glu-Arg

object_name: osteoarthritis


subject: CHEBI:33379

subject_name: erbium


subject: UMLS:C5441529

subject_name: Estrogen Receptor Family, human


subject: PR:000007204

subject_name: estrogen receptor


subject: CHEBI:3095

subject_name: Biguanide

object_name: Hepadnaviridae infectious disease


subject: CHEBI:3095

object_name: DNA Virus Infections


subject: CHEBI:3095

object_name: viral disease


subject: UMLS:C0062525

subject_name: Hyperhep B


subject: UMLS:C0062525


subject: UMLS:C0062525


subject: UMLS:C1328149

object_name: pancreatic neoplasm


subject: CHEBI:66910

subject_name: Axitinib


subject: PUBCHEM.COMPOUND:6096882

subject_name: indocyanine green

object_name: intestinal perforation


subject: PUBCHEM.COMPOUND:6096882

object_name: intestinal atresia


subject: PUBCHEM.COMPOUND:6096882

object_name: intestinal obstruction


subject: PUBCHEM.COMPOUND:6096882

object_name: perinatal necrotizing enterocolitis


subject: PUBCHEM.COMPOUND:6096882

object_name: necrotizing enterocolitis


subject: PUBCHEM.COMPOUND:6096882

object_name: Necrotizing Enterocolitis, AE


subject: PUBCHEM.COMPOUND:6096882

object_name: volvulus of midgut


subject: PUBCHEM.COMPOUND:6096882

object_name: Incarcerated hernia


subject: PUBCHEM.COMPOUND:6096882

object_name: Hirschsprung disease


subject: PUBCHEM.COMPOUND:6096882

object_name: Hirschsprung disease, susceptibility to, 1


subject: PUBCHEM.COMPOUND:6096882

object_name: Invagination


subject: PUBCHEM.COMPOUND:6096882

object_name: intussusception


subject: PUBCHEM.COMPOUND:6096882

object_name: meconium ileus


subject: PUBCHEM.COMPOUND:6096882

object_name: intestinal obstruction in the newborn due to guanylate cyclase 2C deficiency


subject: PUBCHEM.COMPOUND:6096882

object_name: gastroschisis


subject: PUBCHEM.COMPOUND:6096882

object_name: Volvulus


subject: PUBCHEM.COMPOUND:6096882

object_name: Physical trauma


subject: PUBCHEM.COMPOUND:6096882

object_name: Injury


subject: PUBCHEM.COMPOUND:6096882

object_name: Trauma


subject: UNII:C4V974V932

subject_name: Indocyanine green acid form

object_name: intestinal perforation


subject: UNII:C4V974V932

object_name: intestinal atresia


subject: UNII:C4V974V932

object_name: intestinal obstruction


subject: UNII:C4V974V932

object_name: perinatal necrotizing enterocolitis


subject: UNII:C4V974V932

object_name: necrotizing enterocolitis


subject: UNII:C4V974V932

object_name: Necrotizing Enterocolitis, AE


subject: UNII:C4V974V932

object_name: volvulus of midgut


subject: UNII:C4V974V932

object_name: Incarcerated hernia


subject: UNII:C4V974V932

object_name: Hirschsprung disease


subject: UNII:C4V974V932

object_name: Hirschsprung disease, susceptibility to, 1


subject: UNII:C4V974V932

object_name: Invagination


subject: UNII:C4V974V932

object_name: intussusception


subject: UNII:C4V974V932

object_name: meconium ileus


subject: UNII:C4V974V932

object_name: intestinal obstruction in the newborn due to guanylate cyclase 2C deficiency


subject: UNII:C4V974V932

object_name: gastroschisis


subject: UNII:C4V974V932

object_name: Volvulus


subject: UNII:C4V974V932

object_name: Physical trauma


subject: UNII:C4V974V932

object_name: Injury


subject: UNII:C4V974V932

object_name: Trauma


subject: UMLS:C0035750

subject_name: Rocephin

object_name: Acne inversa


subject: CHEBI:29007

subject_name: Ceftriaxone


subject: UNII:L500PR95QA

subject_name: METRONIDAZOLE PHOSPHATE


subject: CHEBI:6909

subject_name: Metronidazole


subject: PUBCHEM.COMPOUND:135512673

subject_name: Rifampicin


subject: CHEBI:63611

subject_name: Moxifloxacin


subject: HMDB:HMDB0015179

subject_name: Rifampin


subject: CHEMBL.COMPOUND:CHEMBL4298210

subject_name: ISCALIMAB

object_name: Sicca Syndrome


subject: UMLS:C5139898

subject_name: iscalimab


subject: UNII:37CQ2C7X93

subject_name: Canakinumab

object_name: mucocutaneous lymph node syndrome


subject: UMLS:C2718754

subject_name: Ilaris


subject: CHEBI:41423

subject_name: Celecoxib

object_name: anti-neutrophil cytoplasmic antibody-associated vasculitis


subject: CHEBI:94366

subject_name: itraconazole


subject: CHEBI:6931

subject_name: Midazolam


subject: PUBCHEM.COMPOUND:135512673


subject: HMDB:HMDB0015179


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: Childhood Soft Tissue Sarcoma


subject: PUBCHEM.COMPOUND:1805

object_name: Adult Soft Tissue Sarcoma


subject: PUBCHEM.COMPOUND:1805

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: PUBCHEM.COMPOUND:1805

object_name: soft tissue sarcoma


subject: PUBCHEM.COMPOUND:1805

object_name: Mesothelioma


subject: PUBCHEM.COMPOUND:1805

object_name: mesothelial neoplasm


subject: PUBCHEM.COMPOUND:1805

object_name: malignant mesothelioma


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: GTOPDB:8089

subject_name: bermekimab


subject: CHEMBL.COMPOUND:CHEMBL2109653

subject_name: BERMEKIMAB


subject: PUBCHEM.COMPOUND:164888937

subject_name: Gallium Ga 68 FAPI-46

object_name: skin cancer


subject: PUBCHEM.COMPOUND:164888937

object_name: brain cancer


subject: PUBCHEM.COMPOUND:164888937

object_name: Malignant Solid Neoplasm


subject: PUBCHEM.COMPOUND:164888937

object_name: thymus cancer


subject: PUBCHEM.COMPOUND:164888937

object_name: cancer of unknown primary site


subject: PUBCHEM.COMPOUND:164888937

object_name: pleural cancer


subject: PUBCHEM.COMPOUND:164888937

object_name: testicular cancer


subject: PUBCHEM.COMPOUND:164888937

object_name: Adrenal Cancer


subject: PUBCHEM.COMPOUND:164888937

object_name: hematopoietic and lymphoid cell neoplasm


subject: PUBCHEM.COMPOUND:164888937

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: PUBCHEM.COMPOUND:164888937

object_name: thyroid gland carcinoma


subject: PUBCHEM.COMPOUND:164888937

object_name: liver carcinoma


subject: PUBCHEM.COMPOUND:164888937

object_name: neuroendocrine neoplasm


subject: PUBCHEM.COMPOUND:164888937

object_name: urothelial carcinoma


subject: PUBCHEM.COMPOUND:164888937

object_name: transitional cell carcinoma


subject: PUBCHEM.COMPOUND:164888937

object_name: cholangiocarcinoma


subject: PUBCHEM.COMPOUND:164888937

object_name: suppressor of tumorigenicity 3


subject: PUBCHEM.COMPOUND:164888937

object_name: cervical carcinoma


subject: PUBCHEM.COMPOUND:164888937

object_name: urinary bladder carcinoma


subject: UMLS:C5237268

subject_name: Gallium Ga 68 FAPi-46

object_name: skin cancer


subject: UMLS:C5237268

object_name: brain cancer


subject: UMLS:C5237268

object_name: Malignant Solid Neoplasm


subject: UMLS:C5237268

object_name: thymus cancer


subject: UMLS:C5237268

object_name: pleural cancer


subject: UMLS:C5237268

object_name: testicular cancer


subject: UMLS:C5237268

object_name: Adrenal Cancer


subject: UMLS:C5237268

object_name: hematopoietic and lymphoid cell neoplasm


subject: UMLS:C5237268

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: UMLS:C5237268

object_name: thyroid gland carcinoma


subject: UMLS:C5237268

object_name: liver carcinoma


subject: UMLS:C5237268

object_name: neuroendocrine neoplasm


subject: UMLS:C5237268

object_name: urothelial carcinoma


subject: UMLS:C5237268

object_name: transitional cell carcinoma


subject: UMLS:C5237268

object_name: cholangiocarcinoma


subject: UMLS:C5237268

object_name: suppressor of tumorigenicity 3


subject: UMLS:C5237268

object_name: cervical carcinoma


subject: UMLS:C5237268

object_name: urinary bladder carcinoma


subject: UMLS:C5926468

subject_name: FAPi-46 GA-68

object_name: skin cancer


subject: UMLS:C5926468

object_name: brain cancer


subject: UMLS:C5926468

object_name: Malignant Solid Neoplasm


subject: UMLS:C5926468

object_name: thymus cancer


subject: UMLS:C5926468

object_name: cancer of unknown primary site


subject: UMLS:C5926468

object_name: pleural cancer


subject: UMLS:C5926468

object_name: testicular cancer


subject: UMLS:C5926468

object_name: Adrenal Cancer


subject: UMLS:C5926468

object_name: hematopoietic and lymphoid cell neoplasm


subject: UMLS:C5926468

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: UMLS:C5926468

object_name: thyroid gland carcinoma


subject: UMLS:C5926468

object_name: liver carcinoma


subject: UMLS:C5926468

object_name: neuroendocrine neoplasm


subject: UMLS:C5926468

object_name: urothelial carcinoma


subject: UMLS:C5926468

object_name: transitional cell carcinoma


subject: UMLS:C5926468

object_name: cholangiocarcinoma


subject: UMLS:C5926468

object_name: suppressor of tumorigenicity 3


subject: UMLS:C5926468

object_name: cervical carcinoma


subject: UMLS:C5926468

object_name: urinary bladder carcinoma


subject: CHEBI:94559

subject_name: Levocetirizine

object_name: Eczema, CTCAE


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: Heartburn


subject: UMLS:C1527137

object_name: Gastroesophageal Reflux Disease, CTCAE


subject: CHEBI:16796

subject_name: Melatonin


subject: CHEBI:16796


subject: UMLS:C0592544

subject_name: Zomacton

object_name: hereditary endocrine growth disease


subject: PUBCHEM.COMPOUND:77014446

subject_name: Ketofol

object_name: endogenous depression


subject: PUBCHEM.COMPOUND:77014446

object_name: major depressive disorder


subject: CHEBI:9123

subject_name: Sertraline

object_name: cocaine abuse


subject: PUBCHEM.COMPOUND:135415564

subject_name: Rifabutin

object_name: Prosthetic infection


subject: CHEBI:45367


subject: CHEBI:17303

subject_name: Morphine

object_name: Arm Fracture


subject: CHEBI:77562

subject_name: rac-crizotinib

object_name: BRAF gene mutation


subject: CHEBI:77562

object_name: Recurrent Malignant Neoplasm


subject: CHEBI:64310

subject_name: Crizotinib


subject: CHEBI:64310


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:63637

subject_name: Vemurafenib


subject: CHEBI:63637


subject: CHEBI:63637

object_name: Embolism, Tumor


subject: CHEBI:63637

object_name: refractory malignant neoplasm


subject: CHEBI:201674

subject_name: Icaritin

object_name: Carcinoma breast stage IV


subject: CHEBI:85994

subject_name: Lenvatinib


subject: CHEBI:64816

object_name: adult acute lymphoblastic leukemia


subject: CHEBI:45783

subject_name: Imatinib

object_name: childhood acute lymphoblastic leukemia


subject: CHEBI:45783


subject: CHEBI:8378

subject_name: Prednisolone


subject: UMLS:C1522140

object_name: liver cancer


subject: UMLS:C4733652

subject_name: FLT3 Inhibitor SKI-G-801

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C3714217

object_name: melanoma


subject: UMLS:C5203465

subject_name: Teniposide Liquid Injection

object_name: adult germ cell tumor


subject: UMLS:C5203465

object_name: germ cell tumor


subject: UMLS:C5203465

object_name: childhood germ cell tumor


subject: UMLS:C5203465

object_name: Germ Cell Cancer


subject: UMLS:C5203465

object_name: Gastrointestinal Carcinoid Tumor


subject: UMLS:C5203465

object_name: granular cell tumor


subject: PUBCHEM.COMPOUND:34698

subject_name: Teniposide


subject: PUBCHEM.COMPOUND:34698


subject: PUBCHEM.COMPOUND:34698


subject: PUBCHEM.COMPOUND:34698


subject: PUBCHEM.COMPOUND:34698


subject: PUBCHEM.COMPOUND:34698


subject: GTOPDB:5962

subject_name: dovitinib

object_name: non-small cell lung carcinoma


subject: UNII:TWF0ML1CK8

subject_name: Fluzoparib

object_name: nonpapillary renal cell carcinoma


subject: UNII:TWF0ML1CK8

object_name: clear cell renal carcinoma


subject: UNII:TWF0ML1CK8

object_name: renal cell adenocarcinoma


subject: UNII:TWF0ML1CK8

object_name: renal cell carcinoma


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: Hemoglobin SS disease with crisis


subject: CHEBI:46195

object_name: Hemoglobin S sickling disorder with crisis


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: UMLS:C2917659


subject: PUBCHEM.COMPOUND:66586232

object_name: opiate dependence


subject: CHEBI:3614

subject_name: Chlorhexidine


subject: CHEBI:231683

subject_name: Anakinra

object_name: myalgic encephalomeyelitis/chronic fatigue syndrome


subject: UNII:9013DUQ28K


subject: PR:000001137

subject_name: interleukin-1 receptor antagonist protein


subject: CHEBI:27547

subject_name: Zeaxanthin

object_name: cognitive disorder


subject: CHEBI:28838

subject_name: Lutein


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: primary peritoneal carcinoma


subject: CHEBI:28939

object_name: papillary serous cystadenocarcinoma


subject: CHEBI:28939

object_name: peritoneal carcinoma


subject: UNII:4FR53SIF3A

subject_name: Blinatumomab

object_name: leukemia, acute lymphocytic, susceptibility to, 1


subject: UNII:4FR53SIF3A

object_name: lymphoblastic leukemia, acute, with lymphomatous features


subject: MESH:D064086

subject_name: Medical Marijuana

object_name: Marijuana Use


subject: MESH:D064086

object_name: opioid use


subject: UMLS:C0813973


subject: UMLS:C0813973


subject: CHEBI:15641

subject_name: 5-methyltetrahydrofolic acid

object_name: Inflammation


subject: CHEBI:15641

object_name: hyperhomocysteinemia


subject: CHEBI:15641

object_name: mortality


subject: PUBCHEM.COMPOUND:135483998


subject: PUBCHEM.COMPOUND:135483998


subject: PUBCHEM.COMPOUND:135483998


subject: PUBCHEM.COMPOUND:135402010


subject: PUBCHEM.COMPOUND:135402010


subject: PUBCHEM.COMPOUND:135402010


subject: CHEBI:20612


subject: CHEBI:20612


subject: CHEBI:20612


subject: UMLS:C4045537

object_name: mild neurocognitive disorder


subject: UMLS:C4045537

object_name: mild cognitive impairment


subject: CHEBI:95165

object_name: acute myeloid leukemia with multilineage dysplasia


subject: CHEBI:50131

subject_name: Decitabine


subject: CHEBI:95044

subject_name: Tosedostat

object_name: De Novo Myelodysplastic Syndrome


subject: CHEBI:95044

object_name: Adult Acute Promyelocytic Leukemia with PML-RARA


subject: CHEBI:95044

object_name: Secondary Myelodysplastic Syndrome


subject: CHEBI:95044

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: CHEBI:95044

object_name: adult acute myeloid leukemia with del(5q)


subject: CHEBI:95044

object_name: Untreated Adult Acute Myeloid Leukemia


subject: CHEBI:95044

object_name: Previously Treated Myelodysplastic Syndrome


subject: CHEBI:95044


subject: CHEBI:95044

object_name: adult acute myeloid leukemia with 11q23 (MLL) abnormalities


subject: CHEBI:135515

subject_name: Bendamustine

object_name: plasma cell leukemia


subject: UMLS:C4721782

subject_name: Pegargiminase

object_name: Childhood Glioblastoma


subject: UMLS:C4721782

object_name: adult glioblastoma


subject: UMLS:C1328192

subject_name: ADI PEG20


subject: UMLS:C1328192


subject: UNII:CI43QFE22O


subject: CHEBI:68646

subject_name: REGORAFENIB


subject: CHEBI:68646


subject: CHEBI:68647

subject_name: Regorafenib


subject: CHEBI:68647


subject: UMLS:C4733624

subject_name: TSP-1 Activator VT1021

object_name: glioblastoma


subject: UMLS:C4733624


subject: UMLS:C4733624


subject: CHEBI:233414

object_name: diffuse midline glioma, H3 K27M-mutant


subject: CHEBI:233414

object_name: diffuse intrinsic pontine glioma


subject: MESH:C552724

subject_name: OKN 007


subject: MESH:C552724


subject: CHEBI:6456

subject_name: Lidocaine

object_name: spontaneous abortion


subject: DRUGBANK:DB19249

subject_name: Bos taurus colostrum

object_name: acute lymphoblastic leukemia


subject: CHEBI:47898

subject_name: Epirubicin

object_name: malignant mesothelioma


subject: UMLS:C3257691

subject_name: rice germ preparation

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C3257691

object_name: obesity


subject: UMLS:C3257691

object_name: Obesity, CTCAE


subject: UMLS:C5962140

subject_name: EGFR Mutant-selective Inhibitor PLB1004

object_name: non-small cell lung carcinoma


subject: UMLS:C0701238

object_name: bipolar disorder


subject: CHEBI:190738

subject_name: Demethylated antipyrine

object_name: stroke disorder


subject: CHEBI:190738

object_name: cerebral infarction


subject: CHEBI:190738

object_name: cerebrovascular disorder


subject: UNII:S798V6YJRP

subject_name: EDARAVONE


subject: UNII:S798V6YJRP


subject: UNII:S798V6YJRP


subject: CHEBI:31530

subject_name: Edaravone


subject: CHEBI:31530


subject: CHEBI:31530


subject: CHEBI:9168

subject_name: Sirolimus

object_name: myeloid leukemia


subject: CHEBI:9168

object_name: chronic leukemia


subject: UniProtKB:P0AED9

subject_name: DCM_ECOLI DNA-cytosine methyltransferase (sprot)

object_name: leukemia


subject: UniProtKB:P0AED9

object_name: childhood leukemia


subject: UniProtKB:P0AED9


subject: UniProtKB:P0AED9

object_name: acute myeloid leukemia


subject: UniProtKB:P0AED9

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: UniProtKB:P0AED9


subject: PR:000001803

subject_name: C-C motif chemokine 28


subject: PR:000001803


subject: PR:000001803


subject: PR:000001803


subject: PR:000001803


subject: PR:000001803


subject: PR:000022407

subject_name: DNA-cytosine methyltransferase


subject: PR:000022407


subject: PR:000022407


subject: PR:000022407


subject: PR:000022407


subject: PR:000022407


subject: CHEBI:50729

subject_name: Mitoxantrone


subject: CHEBI:50729


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911


subject: CHEBI:3139

subject_name: bleomycin

object_name: seminoma


subject: CHEBI:3139

object_name: testicular germ cell tumor


subject: CHEBI:3139

object_name: testis seminoma


subject: UMLS:C4522161

subject_name: Therapeutic Exchange Plasma

object_name: melanoma


subject: CHEBI:95165

object_name: glioma


subject: CHEBI:95165

object_name: medulloblastoma


subject: CHEBI:95165

object_name: childhood medulloblastoma


subject: CHEBI:95165

object_name: adult medulloblastoma


subject: CHEBI:95165

object_name: primitive neuroectodermal tumor


subject: CHEBI:50131

subject_name: Decitabine


subject: CHEBI:50131


subject: CHEBI:50131


subject: CHEBI:50131


subject: CHEBI:50131


subject: DRUGBANK:DB17293

subject_name: Hiltonol


subject: DRUGBANK:DB17293


subject: DRUGBANK:DB17293


subject: DRUGBANK:DB17293


subject: UNII:7KYP9TKT70

subject_name: poly ICLC


subject: UNII:7KYP9TKT70


subject: UNII:7KYP9TKT70


subject: UNII:7KYP9TKT70


subject: UMLS:C0042210

subject_name: Vaccines


subject: UMLS:C0042210


subject: UMLS:C0042210


subject: UMLS:C0042210


subject: UMLS:C0042210


subject: UMLS:C5399710

subject_name: Vaccine [APC]


subject: UMLS:C5399710


subject: UMLS:C5399710


subject: UMLS:C5399710


subject: UMLS:C5399710


subject: GTOPDB:11546

subject_name: aldafermin

object_name: sclerosing cholangitis


subject: GTOPDB:11546

object_name: primary sclerosing cholangitis


subject: CHEMBL.COMPOUND:CHEMBL4298055

subject_name: ALDAFERMIN


subject: CHEMBL.COMPOUND:CHEMBL4298055


subject: UMLS:C5418311


subject: UMLS:C5418311


subject: UMLS:C0796508

subject_name: IDEC In2B8

object_name: adult lymphoma


subject: UMLS:C0796508

object_name: lymphoma


subject: UMLS:C0796508

object_name: pediatric lymphoma


subject: UMLS:C1510800

subject_name: Adenovirus Vector

object_name: herpes zoster


subject: CHEBI:53076

object_name: liver carcinoma


subject: UMLS:C2983753


subject: CHEBI:4814

subject_name: Eprosartan

object_name: hypertension


subject: CHEBI:4814

object_name: Hypertension, CTCAE


subject: CHEBI:4814

object_name: type 2 diabetes mellitus


subject: UMLS:C0115922

subject_name: endogenous pyrogen

object_name: insomnia


subject: UMLS:C0115922

object_name: Insomnia, CTCAE 3.0


subject: UMLS:C0115922

object_name: Insomnia, CTCAE 5.0


subject: PR:000059798

subject_name: ciliary microtubule-associated protein 2


subject: PR:000059798


subject: PR:000059798


subject: UMLS:C0796512

subject_name: CCI 779

object_name: female reproductive system neoplasm


subject: CHEBI:79699

subject_name: Temsirolimus


subject: CHEBI:63632

subject_name: Topotecan


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED

object_name: Advanced cancer


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:229220

subject_name: Repotrectinib


subject: UNII:2P471X1Z11

subject_name: Omalizumab

object_name: COPD, severe early onset


subject: UNII:2P471X1Z11

object_name: chronic obstructive pulmonary disease


subject: UMLS:C0910794


subject: UMLS:C0910794


subject: PUBCHEM.COMPOUND:6096882

subject_name: indocyanine green

object_name: soft tissue neoplasm


subject: UNII:C4V974V932

subject_name: Indocyanine green acid form


subject: CHEBI:499361

subject_name: Aprepitant

object_name: uterine cancer


subject: CHEBI:499361

object_name: tumor of uterus


subject: CHEBI:64321

subject_name: Fosaprepitant

object_name: ovarian cancer


subject: CHEBI:64321

object_name: ovarian neoplasm


subject: CHEBI:64321

object_name: ovarian carcinoma


subject: CHEBI:64321


subject: CHEBI:64321


subject: UNII:7FY24HE2G3

subject_name: Tanakan

object_name: viral pneumonia


subject: CHEBI:3638

subject_name: Chloroquine


subject: UMLS:C5203179

subject_name: Adalimumab Liquid Injection

object_name: ocular cicatricial pemphigoid


subject: UMLS:C5203179

object_name: Stevens-Johnson syndrome


subject: UMLS:C5203179

object_name: Stevens-Johnson Syndrome, CTCAE


subject: UNII:FYS6T7F842

subject_name: Adalimumab


subject: UNII:FYS6T7F842


subject: UNII:FYS6T7F842


subject: CHEBI:135952

subject_name: Zucapsaicin

object_name: osteoarthritis, knee


subject: UMLS:C4727206

subject_name: Lixumistat Acetate

object_name: pancreatic neoplasm


subject: UMLS:C4727206

object_name: exocrine pancreatic carcinoma


subject: UMLS:C4727206

object_name: malignant pancreatic neoplasm


subject: CHEBI:50386

subject_name: cysteamine bitartrate

object_name: schizophrenia


subject: CHEBI:17141

subject_name: Cysteamine


subject: CHEBI:46058

subject_name: TAXOTERE

object_name: head and neck squamous cell carcinoma


subject: UMLS:C4053581

object_name: Neck Carcinoma


subject: UMLS:C4053581

object_name: head and neck neoplasm


subject: UMLS:C4053581

object_name: head and neck cancer


subject: UMLS:C4053581

object_name: urothelial carcinoma


subject: UMLS:C4053581

object_name: transitional cell carcinoma


subject: UMLS:C4053581


subject: PUBCHEM.COMPOUND:57414794

subject_name: Dolutegravir

object_name: HIV cardiomyopathy


subject: CHEBI:63577

subject_name: Lamivudine


subject: CHEBI:63577

object_name: cardiovascular disorder


subject: UMLS:C5784682

subject_name: MALT1 Inhibitor ONO-7018

object_name: B-cell chronic lymphocytic leukemia


subject: UMLS:C5784682

object_name: lymphoma, non-Hodgkin, familial


subject: CHEMBL.COMPOUND:CHEMBL1201458

subject_name: ETHIODIZED OIL

object_name: colon carcinoma


subject: CHEMBL.COMPOUND:CHEMBL1201458

object_name: colorectal cancer


subject: CHEMBL.COMPOUND:CHEMBL1201458

object_name: colon cancer


subject: CHEMBL.COMPOUND:CHEMBL1201458

object_name: Endobronchial metastases


subject: CHEMBL.COMPOUND:CHEMBL1201458

object_name: neoplasm of mediastinum


subject: CHEMBL.COMPOUND:CHEMBL1201458

object_name: pleural neoplasm


subject: CHEMBL.COMPOUND:CHEMBL1201458

object_name: malignant soft tissue neoplasm


subject: CHEMBL.COMPOUND:CHEMBL1201458

object_name: sarcoma


subject: CHEBI:25357

subject_name: mitomycin

object_name: non-small cell lung carcinoma


subject: CHEBI:25357


subject: CHEBI:25357


subject: CHEBI:25357


subject: CHEBI:25357


subject: CHEBI:25357


subject: CHEBI:25357


subject: CHEBI:25357


subject: CHEBI:27504

subject_name: Mitomycin


subject: CHEBI:27504


subject: CHEBI:27504


subject: CHEBI:27504


subject: CHEBI:27504


subject: CHEBI:27504


subject: CHEBI:27504


subject: UNII:AG9MHG098Z

subject_name: Zanubrutinib

object_name: lupus nephritis


subject: CHEBI:18332

subject_name: Levothyroxine

object_name: thyroid gland papillary carcinoma


subject: UMLS:C5706484


subject: UMLS:C5706484

object_name: non-Hodgkin lymphoma


subject: CHEBI:44915

subject_name: Propofol

object_name: cryptorchidism


subject: CHEBI:44915

object_name: cryptorchidism (physical finding)


subject: CHEBI:30762

subject_name: salicylate

object_name: Keratosis plantaris


subject: CHEBI:9008

subject_name: salicylurate


subject: CHEBI:16914

subject_name: Salicylic acid


subject: DRUGBANK:DB11058

subject_name: Petrolatum


subject: CHEBI:72296

subject_name: Apixaban

object_name: arteriosclerosis disorder


subject: CHEBI:31596

subject_name: Febuxostat

object_name: urolithiasis


subject: CHEBI:31596

object_name: hypouricemia, renal 1


subject: CHEBI:31596

object_name: hereditary renal hypouricemia


subject: CHEBI:31596

object_name: hypouricemia, renal


subject: PUBCHEM.COMPOUND:66964417

subject_name: LACTULOSE

object_name: Decompensated cirrhosis of liver


subject: UNII:9U7D5QH5AE


subject: UMLS:C0728720

subject_name: Cardiolite

object_name: myocardial infarction


subject: UMLS:C0728720

object_name: Myocardial Infarction, CTCAE


subject: UMLS:C0728720

object_name: Myocardial Infarction by ECG Finding


subject: UMLS:C0728720

object_name: myocardial ischemia


subject: UMLS:C0728720

object_name: Family history of ischemic heart disease


subject: PUBCHEM.COMPOUND:11422859

object_name: Refractory acute myeloid leukemia


subject: PUBCHEM.COMPOUND:11422859

object_name: acute myelomonocytic leukemia in relapse


subject: CHEBI:94647

subject_name: Tropisetron

object_name: schizophrenia


subject: CHEBI:32269


subject: CHEBI:138016

subject_name: MPA

object_name: Androgen excess


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: PR:000012478

subject_name: rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha


subject: UniProtKB:P27664

subject_name: PDE6A_MOUSE Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha (sprot)


subject: DRUGBANK:DB17468

subject_name: Odetiglucan

object_name: non-small cell lung carcinoma


subject: UMLS:C2698691

subject_name: Imprime PGG


subject: UMLS:C4053665

object_name: Recurrent Childhood Glioblastoma


subject: UMLS:C4053665

object_name: Recurrent Glioblastoma


subject: UMLS:C4053665

object_name: Recurrent WHO Grade 3 Glioma


subject: UMLS:C4053665

object_name: Recurrent WHO Grade 2 Glioma


subject: CHEBI:49166

subject_name: fluorodopa F 18

object_name: Recurrent Adult Brain Neoplasm


subject: CHEBI:49166

object_name: Recurrent Childhood Brain Neoplasm


subject: CHEBI:49166

object_name: Recurrent Brain Neoplasm


subject: CHEBI:5613

subject_name: Haloperidol

object_name: schizophrenia 18


subject: GTOPDB:12990

subject_name: sintilimab

object_name: Advanced Hepatocellular Carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297829

subject_name: SINTILIMAB


subject: UMLS:C4329335

subject_name: IBI 308


subject: CHEBI:144903

subject_name: Pro-Arg-Pro

object_name: Insertional Achilles tendinopathy


subject: CHEBI:61848


subject: PR:000013192


subject: UniProtKB:P05142

subject_name: PRH1_MOUSE Proline-rich protein HaeIII subfamily 1 (sprot)


subject: PR:000013551


subject: PR:000003551

subject_name: ATP-binding cassette sub-family B member 6


subject: UniProtKB:P67986

subject_name: PRIO_CEREN Major prion protein (sprot)


subject: PR:000001886

subject_name: major prion protein


subject: PR:000030465

subject_name: C4b-binding protein alpha chain


subject: PR:000013555

subject_name: proline-rich protein 2


subject: UniProtKB:P05143

subject_name: PRP2_MOUSE Proline-rich protein 2 (sprot)


subject: PR:000032963

subject_name: proline-rich protein HaeIII subfamily 1


subject: PUBCHEM.COMPOUND:57505028

subject_name: Suvorexant

object_name: liver failure


subject: DRUGBANK:DB18078

object_name: diabetic kidney disease


subject: CHEBI:83766

subject_name: Olaparib

object_name: Advanced Soft Tissue Sarcoma


subject: CHEBI:73573

subject_name: Leu-Thr-Asp

object_name: chickenpox


subject: UMLS:C0023548

subject_name: Leukotrienes D


subject: UMLS:C4086713

subject_name: Substance with programmed cell death protein 1 inhibitor mechanism of action (substance)

object_name: non-small cell squamous lung carcinoma


subject: PUBCHEM.COMPOUND:146273261

object_name: ulcerative colitis


subject: PUBCHEM.COMPOUND:146273261

object_name: inflammatory bowel disease 1


subject: PUBCHEM.COMPOUND:4715169

subject_name: 3-(Aminomethyl)-5-methylhexanoic acid

object_name: Post-Mastectomy Pain Syndrome


subject: CHEBI:64356

subject_name: Pregabalin


subject: CHEBI:190008

subject_name: Tianeptine


subject: UNII:L10K286T2H

object_name: prostate disorder


subject: UNII:L10K286T2H

object_name: prostate cancer


subject: UNII:L10K286T2H

object_name: prostate neoplasm


subject: UNII:L10K286T2H

object_name: male reproductive system neoplasm


subject: UNII:L10K286T2H

object_name: male reproductive organ cancer


subject: UNII:L10K286T2H

object_name: male reproductive system disorder


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: recurrent metastatic squamous neck cancer with occult primary


subject: PUBCHEM.COMPOUND:2767

object_name: Neck Squamous Cell Carcinoma of Unknown Primary


subject: PUBCHEM.COMPOUND:2767

object_name: untreated metastatic squamous neck cancer with occult primary


subject: PUBCHEM.COMPOUND:2767

object_name: Recurrent Salivary Gland Cancer


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IVB Major Salivary Gland Cancer AJCC v7


subject: PUBCHEM.COMPOUND:2767

object_name: stage IVB salivary gland cancer


subject: PUBCHEM.COMPOUND:2767

object_name: stage IVC salivary gland cancer


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IVC Major Salivary Gland Cancer AJCC v7


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IVA Major Salivary Gland Cancer AJCC v7


subject: PUBCHEM.COMPOUND:2767

object_name: stage IVA salivary gland cancer


subject: CHEBI:4672

subject_name: Docetaxel

object_name: Laryngeal squamous cell carcinoma recurrent


subject: CHEBI:4672

object_name: Hypopharyngeal squamous cell carcinoma recurrent


subject: CHEBI:4672

object_name: Oropharyngeal squamous cell carcinoma recurrent


subject: CHEBI:4672

object_name: Nasopharyngeal squamous cell carcinoma recurrent


subject: CHEBI:4672

object_name: Recurrent Lip and Oral Cavity Squamous Cell Carcinoma


subject: CHEBI:4672

object_name: salivary gland squamous cell carcinoma


subject: CHEBI:4672


subject: CHEBI:4672

object_name: Recurrent Sinonasal Squamous Cell Carcinoma


subject: CHEBI:4672

object_name: Stage IVA Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:4672

object_name: stage IVC squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: CHEBI:4672

object_name: stage IVB squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: CHEBI:4672

object_name: stage IVA squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: CHEBI:4672

object_name: Laryngeal verrucous carcinoma recurrent


subject: CHEBI:4672

object_name: Verrucous carcinoma of the oral cavity recurrent


subject: CHEBI:4672

object_name: Recurrent Salivary Gland Cancer


subject: CHEBI:4672

object_name: Stage IVB Major Salivary Gland Cancer AJCC v7


subject: CHEBI:4672

object_name: stage IVB salivary gland cancer


subject: CHEBI:4672

object_name: stage IVC salivary gland cancer


subject: CHEBI:4672

object_name: Stage IVC Major Salivary Gland Cancer AJCC v7


subject: CHEBI:4672

object_name: Stage IVA Major Salivary Gland Cancer AJCC v7


subject: CHEBI:4672

object_name: stage IVA salivary gland cancer


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: UMLS:C2348275

subject_name: Dietary Nitrate

object_name: peripheral vascular disease


subject: UMLS:C2348275

object_name: peripheral arterial disease


subject: UMLS:C2348275

object_name: Inflammation


subject: UMLS:C2348275

object_name: Ambulation Difficulty


subject: CHEBI:81579

subject_name: Erythropoietin

object_name: Pulmonary Artery Intimal Sarcoma


subject: CHEBI:81579

object_name: Lubs syndrome


subject: CHEBI:81579

object_name: Perinatal stroke


subject: CHEBI:81579

object_name: Neonatal stroke


subject: UNII:CKP8AS5W73

subject_name: ULEVOSTINAG

object_name: adult lymphoma


subject: UNII:CKP8AS5W73

object_name: lymphoma


subject: UNII:CKP8AS5W73

object_name: pediatric lymphoma


subject: UNII:CKP8AS5W73

object_name: Solid Neoplasm


subject: DRUGBANK:DB18789

subject_name: Ulevostinag


subject: DRUGBANK:DB18789


subject: DRUGBANK:DB18789


subject: DRUGBANK:DB18789


subject: UMLS:C1831930

object_name: plasma cell myeloma


subject: CHEBI:94265

subject_name: Cerubidin

object_name: hematopoietic and lymphoid cell neoplasm


subject: CHEBI:94265

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: CHEBI:64677

subject_name: Cerubidine


subject: CHEBI:64677


subject: CHEBI:41977

subject_name: Daunorubicin


subject: CHEBI:41977


subject: UNII:6I3O3W6O3B

subject_name: Entospletinib

object_name: acute myeloid leukemia by FAB classification


subject: UNII:6I3O3W6O3B

object_name: acute myeloid leukemia


subject: UNII:6I3O3W6O3B


subject: UNII:6I3O3W6O3B

object_name: hematopoietic and lymphoid system neoplasm


subject: UNII:6I3O3W6O3B


subject: UNII:G2AE2VE07O

subject_name: Revefenacin

object_name: respiratory failure


subject: UNII:G2AE2VE07O

object_name: acute respiratory failure


subject: CHEBI:43968

subject_name: Meropenem

object_name: septic peritonitis


subject: CHEBI:58470

object_name: rheumatoid arthritis


subject: CHEBI:18388

subject_name: Apigenin


subject: PUBCHEM.COMPOUND:3495

subject_name: Glycyrrhizin


subject: CHEBI:29807


subject: PUBCHEM.COMPOUND:5185849

subject_name: b-Boswellic acid


subject: CHEBI:192014

subject_name: Boswellic acid


subject: UMLS:C5447482

subject_name: Ligufalimab

object_name: Myelodysplasia


subject: UMLS:C5447482

object_name: Adult Myelodysplastic Syndrome


subject: UMLS:C5447482

object_name: childhood myelodysplastic syndrome


subject: UMLS:C5447482

object_name: Myelodysplastic Syndrome, CTCAE


subject: PUBCHEM.COMPOUND:66586232

object_name: CLABSI - central line associated bloodstream infection


subject: PUBCHEM.COMPOUND:66586232

object_name: Line insertion site


subject: CHEBI:3614

subject_name: Chlorhexidine


subject: CHEBI:3614


subject: CHEBI:185135

subject_name: Polyvidone


subject: CHEBI:185135


subject: CHEBI:8347

subject_name: Povidone-iodine


subject: CHEBI:8347


subject: CHEBI:8228

subject_name: Pioglitazone

object_name: chronic granulomatous disease


subject: UMLS:C0876066

subject_name: Levulan Kerastick

object_name: skin carcinoma


subject: UMLS:C0876066

object_name: skin neoplasm


subject: UMLS:C0876066

object_name: skin cancer


subject: UMLS:C0876066

object_name: actinic keratosis


subject: UMLS:C0876066

object_name: Solar elastosis


subject: CHEBI:17549

subject_name: Aminolevulinic acid


subject: CHEBI:17549


subject: CHEBI:17549


subject: UNII:KX7K68Z2UH

subject_name: ENZASTAURIN HYDROCHLORIDE

object_name: glioblastoma


subject: UNII:KX7K68Z2UH

object_name: Childhood Glioblastoma


subject: UNII:KX7K68Z2UH

object_name: adult glioblastoma


subject: UMLS:C1765315

subject_name: Enzastaurin Hydrochloride


subject: UMLS:C1765315


subject: UMLS:C1765315


subject: UMLS:C5772966

object_name: Inflammation


subject: CHEBI:6887

subject_name: Methylphenidate

object_name: Hair-pulling


subject: CHEBI:6801

subject_name: Metformin

object_name: Barrett esophagus


subject: CHEBI:6801

object_name: carcinoma of esophagus


subject: CHEBI:6801

object_name: esophageal cancer


subject: CHEBI:6801

object_name: Childhood Esophageal Carcinoma


subject: CHEBI:6801

object_name: neoplasm of esophagus


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: malignant tumor of nasopharynx


subject: UNII:O6L62LZJ0Q

object_name: treatment resistant depression


subject: UNII:O6L62LZJ0Q


subject: UMLS:C5222448

subject_name: Hydromorphone Hydrochloride Liquid Injection

object_name: cancer pain


subject: UNII:D87YGH4Z0Q

subject_name: Omacor

object_name: colorectal cancer


subject: UNII:D87YGH4Z0Q

object_name: colorectal carcinoma


subject: UNII:D87YGH4Z0Q

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UNII:D87YGH4Z0Q

object_name: Lynch syndrome


subject: UNII:D87YGH4Z0Q

object_name: Hereditary Nonpolyposis Colorectal Cancer


subject: UNII:981TME683S

subject_name: Ropeginterferon alfa-2b

object_name: chronic hepatitis B virus infection


subject: PUBCHEM.COMPOUND:58291210

subject_name: Oligofructose

object_name: type 2 diabetes mellitus


subject: MESH:C120489

subject_name: oligofructose


subject: PUBCHEM.COMPOUND:3367

object_name: childhood kidney cell carcinoma


subject: CHEBI:82339

subject_name: Merphalan


subject: CHEBI:28876

subject_name: Melphalan


subject: CHEBI:75331

subject_name: benzotriazole

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:75331

object_name: obesity


subject: CHEBI:75331

object_name: Obesity, CTCAE


subject: UMLS:C0676494

subject_name: bladder tumor-associated antigen


subject: UMLS:C0676494


subject: UMLS:C0676494


subject: GTOPDB:9592

subject_name: tislelizumab

object_name: Stage III Esophageal Cancer


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: UMLS:C4053664


subject: CHEBI:39585

subject_name: Carbidopa

object_name: pervasive developmental disorder


subject: CHEBI:39585

object_name: autism


subject: CHEBI:39585

object_name: autism spectrum disorder


subject: PR:000008826

subject_name: basement membrane-specific heparan sulfate proteoglycan core protein


subject: PR:000008826


subject: PR:000008826


subject: UMLS:C0031669

subject_name: Phospholipase C


subject: UMLS:C0031669


subject: UMLS:C0031669


subject: UMLS:C5555610

subject_name: PKMYT1 Inhibitor RP-6306

object_name: Adult Solid Neoplasm


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL

object_name: gestational diabetes


subject: CHEBI:36704

subject_name: Imiquimod

object_name: inflammatory bowel disease


subject: UNII:AHI9T7EDX6

subject_name: Pneumovax 23


subject: UNII:AHI9T7EDX6


subject: UNII:AHI9T7EDX6


subject: RXCUI:287523


subject: RXCUI:287523


subject: RXCUI:287523


subject: CHEBI:168396

subject_name: Mycophenolic acid

object_name: chronic liver failure


subject: CHEBI:168396

object_name: Renal Failure, CTCAE


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: DRUGBANK:DB16536

subject_name: Birch bark extract

object_name: junctional epidermolysis bullosa


subject: DRUGBANK:DB16536

object_name: epidermolysis bullosa dystrophica


subject: DRUGBANK:DB16536

object_name: skin disorder


subject: DRUGBANK:DB16536

object_name: genetic disease


subject: DRUGBANK:DB16536

object_name: Rheumatism


subject: DRUGBANK:DB16536

object_name: connective tissue disorder


subject: DRUGBANK:DB16536

object_name: Fetal anomaly


subject: UMLS:C5669860


subject: UMLS:C5669860


subject: UMLS:C5669860


subject: UMLS:C5669860


subject: UMLS:C5669860


subject: UMLS:C5669860


subject: UMLS:C5669860


subject: UMLS:C4724780

subject_name: Vitis vinifera extract

object_name: Mental deterioration


subject: UMLS:C4724780

object_name: Cognitive impairment


subject: UMLS:C4724780

object_name: Abnormal nervous system electrophysiology


subject: DRUGBANK:DB10640

subject_name: Beet

object_name: Menopause present (finding)


subject: DRUGBANK:DB10640

object_name: Menopause


subject: UMLS:C0085297

subject_name: immunoglobulins, intravenous

object_name: kidney failure


subject: CHEBI:15698

subject_name: Deoxycytidine

object_name: inborn mitochondrial myopathy


subject: CHEBI:17748

subject_name: Thymidine


subject: CHEBI:35625

subject_name: EC 3.5.2.6 (beta-lactamase) inhibitor

object_name: bronchiectasis


subject: UMLS:C2917454

subject_name: beta Lactamase Inhibitor [EPC]


subject: CHEBI:77181

subject_name: gentian violet

object_name: Acne inversa


subject: CHEBI:125628

subject_name: Alisertib

object_name: Plasma cell myeloma refractory


subject: CHEBI:50692

subject_name: Mifepristone

object_name: cocaine dependence


subject: UMLS:C3152625

subject_name: Pneumococcal 13-valent conjugate vaccine

object_name: plasma cell myeloma


subject: UMLS:C3152625

object_name: Plasma cell tumor, malignant


subject: UMLS:C3152625

object_name: plasma cell neoplasm


subject: UMLS:C0770694

subject_name: trivalent influenza vaccine


subject: UMLS:C0770694


subject: UMLS:C0770694


subject: UMLS:C5417864

subject_name: Individualized MVA-based Vaccine TG4050

object_name: ovarian cancer


subject: UMLS:C5417864

object_name: ovarian carcinoma


subject: UMLS:C5417864

object_name: malignant epithelial tumor of ovary


subject: UMLS:C5417864

object_name: Carcinoma of peritoneum


subject: UMLS:C5417864

object_name: peritoneal carcinoma


subject: UMLS:C5417864

object_name: fallopian tube carcinoma


subject: UMLS:C5417864

object_name: fallopian tube cancer


subject: CHEBI:18332

subject_name: Levothyroxine

object_name: hypopituitarism


subject: CHEBI:18332

object_name: Hypopituitarism, CTCAE


subject: CHEBI:18332

object_name: hyperlipidemia


subject: CHEBI:18258

subject_name: Liothyronine

object_name: central congenital hypothyroidism


subject: CHEBI:18258

object_name: isolated thyroid-stimulating hormone deficiency


subject: CHEBI:18258


subject: CHEBI:18258


subject: CHEBI:18258


subject: UNII:FYS6T7F842

subject_name: Adalimumab

object_name: Early Rheumatoid Arthritis


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: PUBCHEM.COMPOUND:16129616

subject_name: Calcitonin

object_name: Amputation Stumps


subject: CHEBI:135973

subject_name: Miacalcic


subject: UNII:DF35I47HCM

subject_name: CALCITONIN